Name and Surname: Mehmet Birhan YILMAZ

Date of Birth: March 11, 1974

Place of Birth: Torbali/Izmir/Türkiye

Marital Status: Married (2005) with two daughters (Dilara and Meyra)

Current Place of Work: Academic Staff, Professor of Cardiology, Dokuz Eylul University, Faculty of Medicine, Department of Cardiology, Izmir, 35340, Türkiye;

Home Address: Aras Sokak, No:15, N Concept Apt, Kat:3, Daire:18, Narlıdere, Izmir, Türkiye

Email:prof.dr.mbyilmaz@gmail.com,  mehmet.birhan.yilmaz@tkd.org.tr, birhan.yilmaz@deu.edu.tr

(https://www.linkedin.com/in/mehmet-birhan-y%C4%B1lmaz-360395342/)

Departmental Office Phone: +90 232 4124107 Mobile Phone: +90 505 2927442   

Vocational Interests: Acute and Chronic Heart Failure, Co-morbidities, Atrial fibrillation, Pulmonary Hypertension

Academic Interests: Heart failure, Heart and Brain Interaction, Clinical Trials, Biotechnology, Artificial Intelligence in Chronic Noncommunicable Diseases

Education and Training:

Career:

Memberships and Administrative Positions:

Turkish Society of Cardiology (TSC) [Certification: The Turkish Board on Cardiology of TSC],

Member of Working Groups on Heart Failure of TSC (2012-2016),

President of Heart Failure Working Group of TSC (2014-2016)

Board Member of Health Research Unit of TUBITAK (The Scientific and Technological Research Council of Turkey (2013-2017),

Fellow of ESC (FESC, 2010), Fellow of ACC (FACC, 2015), Fellow of Heart Failure Association of ESC (FHFA, 2015),

Executive Board Member of Turkish Society of Cardiology (2016-2018),

Associate Editor of Anatolian Journal of Cardiology (SCI-E), European Journal of Heart Failure (SCI) and ESC Heart Failure (SCI-E)  journals,  Editor in Chief of Journal of Basic and Clinical Health Sciences (ESCI)

External advisory board member of ERA-CVD, a new ERA‐Net Cofund action (European Research Area Network co-funded by the European Commission, EC, 2018-2022)

Board Member of Izmir Biomedicine and Genome Center (2020-2023)

Dokuz Eylul University Technology Transfer Office Coordinator of Health Campus (DETTO, 2019-2023)

Board Member of Heart Failure Association of the European Society of Cardiology (2022-2024), Chairperson of Heart and Brain Study Group of HFA (2022-2024), Chairperson of Acute Heart Failure Committee (2024-2026) of HFA,

Governor of ACC Istanbul Chapter (2024-2026)

Vice President of Health Institutes of Türkiye (TUSEB, ww.tuseb.gov.tr, 2024-).

Coordinator of Heart Failure Outpatient Unit of Cardiology Department of Dokuz Eylul University (2023-)

Research Experience:

1-PI and/or NC and/or SC member in phase II-III CV Clinical Trials of CSPP100F2301, ATMOSPHERE; CSPP100A2368, ASTRONAUT; CLCZ696B2314, PARADIGM-HF; MIPO3801011; TRUE-AHF (NC); CLCZ696B2228, TITRATION, ITCA 650-CLP-107;  RIVAROXAFL3003-PIONEER;  CRLX030A2209, RELAX-REPEAT;  RIVAROXACS2002- GEMINI;  TRACER P04736;  ATLAS ACS 2 – TIMI 51;  CRLX030A2301, RELAX-AHF-2;  FOURIER; CACZ885M2301, CANTOS; RIVAROXHFA3001- COMMANDER-HF (NC); CLCZ696B2401, TRANSITION, PARAGON-HF (NC), VICTORIA, CACZ885M2301, CANTOS-OLE-Extension; CLCZ696B2317, PARADIGM-Extension (NC); FIDELIO; FIGARO; CLCZ696D2301;  LCZ696G2301, PARADISE-MI (NC);  ESPERION 1002-043; GALACTIC-HF (NC);  Dal-301-Dal-GENE Trial, FINE-ARTS-HF (NC),  HERMES, BALANCED-HF (NC), BALANCED-HF (NC), BaxDuo Prevent HF,

2-PI in registries of QUALIFY, REPORT HF; GARFIELD;  AFGEN-EORP;  SELFIE-TR (. Snapshot evaluation of acute and chronic heart failure in real-life in Turkey Registry), SMYRNA-HF, TREAT-HF Surveilllance, senior author of Trends-HF Registry Project

3-MC member of COST action, CA17129: Catalysing transcriptomics research in cardiovascular disease, 2018-2022

A.      Papers in International Peer-Reviewed Journals (ORCID ID: 0000-0002-8169-8628, google scholar h index:68, WoS core h index 50, Scopus h index:50

https://scholar.google.com/citations?user=yVTdquAAAAAJ&hl=en&authuser=1&oi=ao):

A1.  Arayici ME, Kilic ME, Yilmaz MB. High and Low Adherence to Mediterranean and DASH Diet Patterns and the Risk of Heart Failure: A Meta-Analysis of Observational Studies. Life (Basel). 2025 Jan 7;15(1):63. doi: 10.3390/life15010063.

A2.  Ata N, Çöllüoğlu İT, Şahin A, Yilmaz MB, Nalbantgil S, Birinci Ş, Ülgü MM, Kanik EA, Ural D, Asarcikli LD, Demir E, Çavuşoğlu Y, Murat S, Çelik A. Epidemiology of heart failure in Türkiye. Turk J Med Sci. 2024 May 7;54(7):1447-1454. doi: 10.55730/1300-0144.5930.

A3.  Nalbantgil S, Demir E, Çelik A, Çöllüoğlu İT, Ata N, Yilmaz MB, Şahin A, Ural D, Ülgü MM, Kanik EA, Asarcikli LD, Çavuşoğlu Y, Murat S, Birinci Ş. Medical and advanced heart failure therapies in Türkiye. Turk J Med Sci. 2024 May 7;54(7):1470-1477.

A4.  Şahin A, Yilmaz MB, Çelik A, Çöllüoğlu İT, Ural D, Asarcikli LD, Nalbantgil S, Demir E, Çavuşoğlu Y, Murat S, Kanik EA, Ata N, Ülgü MM, Birinci Ş. Outcomes of patients with heart failure in Türkiye. Turk J Med Sci. 2024 Jun 14;54(7):1488-1496. doi: 10.55730/1300-0144.5935.

A5.  Sinan UY, Yilmaz MB, Temizhan A, Yuksel UC, Gungor B, Kemaloglu Oz T, Kus M, Ozdogan O, Kayikcioglu M, Tokgozoglu L. Assessment of dyslipidemia management in Turkey using a Delphi panel. Sci Rep. 2024 Dec 28;14(1):31307. doi: 10.1038/s41598-024-82780-2.

A6.  Kilic ME, Yilmaz MB. Gastroprotection in Heart Failure and Outcomes: A Systematic Review of Proton Pump Inhibitors and Histamine-2 Receptor Antagonists. Cardiovasc Drugs Ther. 2024 Dec 14. doi:10.1007/s10557-024-07660-3.

A7.  Yilmaz MB, Celik A, Colluoglu T, Sahin A, Ural D, Kanik A, Ata N, Ulgu MM, Birinci Ş. Real-Life Individual Comparison of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure and Diabetes Mellitus. Am J Cardiovasc Drugs. 2024 Nov 28. doi: 10.1007/s40256-024-00698-6.

A8.  Sahin A, Celik A, Ural D, Colluoglu IT, Ata N, Kanik EA, Ulgu MM, Birinci S, Yilmaz MB. Impact of implantable cardioverter defibrillators on mortality in heart failure receiving quadruple guideline-directed medical therapy: apropensity score-matched study. BMC Med. 2024 Nov 18;22(1):539. doi:10.1186/s12916-024-03761-w.

A9.  Vardeny O, Vaduganathan M, Claggett BL, Desai AS, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Matsumoto S, Merkely B, Zieroth S, Yilmaz MB, Lay-Flurrie J, Viswanathan P, Horvat-Broecker A, Scalise A, McMurray JJV, Solomon SD. Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction. JAMA Cardiol. 2025 Jan 1;10(1):42-48. doi: 10.1001/jamacardio.2024.4539.

A10.           Yalta K, Madias JE, Kounis NG, Y-Hassan S, Polovina M, Altay S, Mebazaa A, Yilmaz MB, Lopatin Y, Mamas MA, Gil RJ, Thamman R, Almaghraby A, Bozkurt B, Bajraktari G, Fink T, Traykov V, Manzo-Silberman S, Mirzoyev U, Sokolovic S, Kipiani ZV, Linde C, Seferovic PM. Takotsubo Syndrome: An International Expert Consensus Report on Practical Challenges and Specific Conditions (Part-2:Specific Entities, Risk Stratification and Challenges After Recovery). Balkan Med J. 2024 Oct 31;41(6):442-457. doi: 10.4274/balkanmedj.galenos.2024.2024-9-99.

A11.           Yalta K, Madias JE, Kounis NG, Y-Hassan S, Polovina M, Altay S, Mebazaa A, Yilmaz MB, Lopatin Y, Mamas MA, Gil RJ, Thamman R, Almaghraby A, Bozkurt B, Bajraktari G, Fink T, Traykov V, Manzo-Silberman S, Mirzoyev U, Sokolovic S, Kipiani ZV, Linde C, Seferovic PM. Takotsubo Syndrome: An International Expert Consensus Report on Practical Challenges and Specific Conditions (Part-1: Diagnostic and Therapeutic Challenges). Balkan Med J. 2024 Oct 31;41(6):421-441. doi: 10.4274/balkanmedj.galenos.2024.2024-9-98.

A12.           Arayici ME, Kilic ME, Yilmaz MB. The Impact of Hormone Replacement Therapy on the Risk of Heart Failure in Postmenopausal Women: A Meta-Analysis of Clinical and Observational Studies. Pharmacoepidemiol Drug Saf. 2024 Oct;33(10):e70029. doi: 10.1002/pds.70029.

A13.           Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Chang-Sheng M, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesova E, Kang S, Katova T, Kosiborod MN, Latkovskis G, Lee AP, Linssen GCM, Llamas-Esperón G, Mareev V, Martinez FA, Melenovský V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov L, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Kolkhof P, Viswanathan P; FINEARTS-HF Committees and Investigators. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2024 Sep 1. doi:10.1056/NEJMoa2407107.

A14.           Gunes H, Gunes H, Dagli M, Kirişçi M, Özbek M, Atilla N, Yılmaz MB. Association of soluble ST2 Level with 6-month Mortality and/or Recurrent Cardiovascular-Related Hospitalization in Pulmonary Embolism. Arq Bras Cardiol. 2024 Feb 23;121(2):e20230040. Portuguese, English. doi: 10.36660/abc.20230040.

A15.           Arayici ME, Gunes H, Ellidokuz H, Yilmaz MB. The efficacy and safety of soluble guanylate cyclase modulation in patients with heart failure: a comprehensive meta-analysis of randomized controlled trials. Sci Rep. 2024 Mar 24;14(1):6987. doi: 10.1038/s41598-024-57695-7.

A16.           Çetin Güvenç R, Güvenç TS, Çağlar ME, Al Arfaj AA, Behrad A, Yılmaz MB. Digoxin is Not Related to Mortality in Patients with Heart Failure: Results from the SELFIE-TR Registry. Am J Cardiovasc Drugs. 2024 May;24(3):399-408. doi: 10.1007/s40256-024-00639-3. Epub 2024 Apr 4.

A17.           Çöllüoğlu İT, Çelik A, Ata N, Ural D, Şahin A, Ulgu MM, Kanık EA, Birinci Ş, Yılmaz MB. Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy. Int J Cardiol. 2024 Jul 15;407:132109. doi: 10.1016/j.ijcard.2024.132109.

A18.           Solomon SD, Ostrominski JW, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Ma CS, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesová E, Kang SM, Katova T, Kosiborod MN, Latkovskis G, Lee AP, Linssen GCM, Llamas-Esperón G, Mareev V, Martinez FA, Melenovský V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov LG, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Viswanathan P, McMurray JJV. Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial. Eur J Heart Fail. 2024 Jun;26(6):1334-1346. doi: 10.1002/ejhf.3266.

A19.           Okan T, Doruk M, Ozturk A, Topaloglu C, Dogdus M, Yilmaz MB. Evaluation of Plasma Atherogenic Index, Triglyceride-Glucose Index and Other Lipid Ratios as Predictive Biomarkers of Coronary Artery Disease in Different Age Groups. Diagnostics (Basel). 2024 Jul 11;14(14):1495. doi: 10.3390/diagnostics14141495.

A20.           Mullens W, Dauw J, Gustafsson F, Mebazaa A, Steffel J, Witte KK, Delgado V, Linde C, Vernooy K, Anker SD, Chioncel O, Milicic D, Hasenfuß G, Ponikowski P, Stephan von Bardeleben R, Koehler F, Ruschitzka F, Damman K, Schwammenthal E, Testani JM, Zannad F, Böhm M, Cowie MR, Dickstein K, Jaarsma T, Filippatos G, Volterrani M, Thum T, Adamopoulos S, Cohen-Solal A, Moura B, Rakisheva A, Ristic A, Bayes-Genis A, Van Linthout S, Tocchetti CG, Savarese G, Skouri H, Adamo M, Amir O, Yilmaz MB, Simpson M, Tokmakova M, González A, Piepoli M, Seferovic P, Metra M, Coats AJS, Rosano GMC. Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2024 Jan 25. doi: 10.1002/ejhf.3150.

A21.           Celik A, Sahin A, Ata N, Colluoglu IT, Ural D, Kanik EA, Ayvali MO, Ulgu MM, Birinci S, Yilmaz MB. Navigating Heart Failure: Unveiling Sex Disparities in Guideline-Directed Medical Therapy Combinations. Am J Cardiol. 2024 Jan 22;216:27-34. doi: 10.1016/j.amjcard.2024.01.017.

A22.           Güvenç RÇ, Güvenç TS, Çavuşoğlu Y, Temizhan A, Yılmaz MB. Usefulness of Age, Creatinine and Ejection Fraction - Modification of Diet in Renal Disease Score for Predicting Survival in Patients with Heart Failure. Arq Bras Cardiol. 2023 Dec;120(12):e20230158. Portuguese, English. doi: 10.36660/abc.20230158.

A23.           Murat S, Çavuşoğlu Y, Yılmaz MB, Yıldırımtürk Ö, Ülvan N, Çelik A, Küçük M, Kılıçaslan B, Nalbantgil S, Yiğit Z, Altay H. Patient Perception, Knowledge and Adaptation in The Management of Heart Failure: A Multicenter, Cross-Sectional, Observational, Questionnaire-Based Study: ADAPTATION HF. Turk Kardiyol Dern Ars. 2024 Jan;52(1):18-26. English. doi: 10.5543/tkda.2023.53574.

A24.           Şahin A, Çöllüoğlu T, Çelik A, Ata N, Yılmaz MB, Ural D, Kanık A, Ayvalı MO, Ülgü MM, Birinci Ş. Exploring Regional Disparities in Heart Failure Epidemiology and Outcomes: A Comprehensive Study Across Geographical Regions in Türkiye. Balkan Med J. 2024 Jan 3;41(1):47-53. doi:10.4274/balkanmedj.galenos.2023.2023-10-5.

A25.           Skouri HN, Çavuşoğlu Y, Bennis A, Klug E, Ogola EN, Bader F, Al Saffar HB, Ragy H, Alhumood KA, Abdelhamid M, Yılmaz MB, Tabbalat R. Expert Recommendations to Bridge Gaps in Heart Failure Patient Support in the Middle East and Africa Region. Anatol J Cardiol. 2024 Jan;28(1):2-18. doi:10.14744/AnatolJCardiol.2023.3517.

A26.            Adamo M, Chioncel O, Pagnesi M, Bayes-Genis A, Abdelhamid M, Anker SD, Antohi EL, Badano L, Ben Gal T, Böhm M, Delgado V, Dreyfus J, Faletra FF, Farmakis D, Filippatos G, Grapsa J, Gustafsson F, Hausleiter J, Jaarsma T, Karam N, Lund L, Lurz P, Maisano F, Moura B, Mullens W, Praz F, Sannino A, Savarese G, Tocchetti CG, van Empel VPM, von Bardeleben RS, Yilmaz MB, Zamorano JL, Ponikowski P, Barbato E, Rosano GMC, Metra M. Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. Eur J Heart Fail. 2024 Jan;26(1):18-33. doi: 10.1002/ejhf.3106.

A27.           Çelik A, Çöllüoğlu İT, Şahin A, Ural D, Yılmaz MB, Ata N. Why has the incidence of heart failure decreased by half in Türkiye?-Authors' reply. Lancet Reg Health Eur. 2023 Oct 28;35:100762. doi: 10.1016/j.lanepe.2023.100762.

A28.           Celik A, Ural A, Sahin A,  Colluoglu IT,  Kanik EA, Ata N, Arugaslan E, Demir E, Ayvali MO, Ulgu MM, Temizhan A, Cavusoglu Y, Acar RD, Nalbantgil S, Dinc Asarcikli L, Murat S, Birinci S, Yilmaz MB. Trends in heart failure between 2016 and 2022 in Türkiye (TRends-HF): a nationwide retrospective cohort study of 85 million individuals across entire population of all ages. The Lancet Regional Health–Europe, Open Access, Published: September 04, 2023 DOI:https://doi.org/10.1016/j.lanepe.2023.100723

A29.           Docherty KF, McMurray JJV, Diaz R, Felker GM, Metra M, Solomon SD, Adams KF, Böhm M, Brinkley DM, Echeverria LE, Goudev AR, Howlett JG, Lund M, Ponikowski P, Yilmaz MB, Zannad F, Claggett BL, Miao ZM, Abbasi SA, Divanji P, Heitner SB, Kupfer S, Malik FI, Teerlink JR. The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF. J Card Fail. 2023 Sep 7:S1071-9164(23)00316-0. doi:10.1016/j.cardfail.2023.08.020.

A30.           Çetin Güvenç R, Güvenç TS, Akıl MA, Bekar L, Vural MG, Yılmaz MB. Estimated plasma volume is not a robust indicator of the severity of congestion in patients with heart failure. Am J Med Sci. 2023 Aug 26:S0002-9629(23)01317-4. doi: 10.1016/j.amjms.2023.08.008.

A31.           Abdelhamid M, Al Ghalayini K, Al-Humood K, Altun B, Arafah M, Bader F, Ibrahim M, Sabbour H, Shawky Elserafy A, Skouri H, Yilmaz MB. Regional expert opinion: Management of heart failure with preserved ejection fraction in the Middle East, North Africa and Turkey. ESC Heart Fail. 2023 Aug 2. doi: 10.1002/ehf2.14456. Epub ahead of print.

A32.           Doehner W, Jelena Č, Yilmaz MB, Coats AJ. Heart failure & the Heart-Brain axis. QJM. 2023 Jul 22:hcad179. doi: 10.1093/qjmed/hcad179. Epub ahead of print.

A33.           Arslan S, Şahin NÖ, Bayyurt B, Berkan Ö, Yılmaz MB, Aşam M, Ayaz F. Role of lncRNAs in Remodeling of the Coronary Artery Plaques in Patients with Atherosclerosis. Mol Diagn Ther. 2023 Sep;27(5):601-610. doi:10.1007/s40291-023-00659-w. Epub 2023 Jun 22.

A34.           Chioncel O, Adamo M, Nikolaou M, Parissis J, Mebazaa A, Yilmaz MB, Hassager C, Moura B, Bauersachs J, Harjola VP, Antohi EL, Ben-Gal T, Collins SP, Iliescu VA, Abdelhamid M, Čelutkienė J, Adamopoulos S, Lund LH, Cicoira M, Masip J, Skouri H, Gustafsson F, Rakisheva A, Ahrens I, Mortara A, Janowska EA, Almaghraby A, Damman K, Miro O, Huber K, Ristic A, Hill L, Mullens W, Chieffo A, Bartunek J, Paolisso P, Bayes-Genis A, Anker SD, Price S, Filippatos G, Ruschitzka F, Seferovic P, Vidal-Perez R, Vahanian A, Metra M, McDonagh TA, Barbato E, Coats AJS, Rosano GMC. Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. Eur J Heart Fail. 2023 Jul;25(7):1025-1048. doi: 10.1002/ejhf.2918. Epub 2023 Jun 13.

A35.           Çelik A, Kılıçaslan B, Temizhan A, Güvenç TS, Altay H, Çavuşoğlu Y, Yılmaz MB, Yıldırımtürk Ö, Nalbantgil S, Ural D. How to Use Natriuretic Peptides in Patients with Heart Failure with Non-Reduced Ejection Fraction? Anatol J Cardiol. 2023 Jun;27(6):308-318. doi: 10.14744/AnatolJCardiol.2023.3297.

A36.           Metra M, Tomasoni D, Adamo M, Bayes-Genis A, Filippatos G, Abdelhamid M, Adamopoulos S, Anker SD, Antohi L, Böhm M, Braunschweig F, Gal TB, Butler J, Cleland JGF, Cohen-Solal A, Damman K, Gustafsson F, Hill L, Jankowska EA, Lainscak M, Lund LH, McDonagh T, Mebazaa A, Moura B, Mullens W, Piepoli M, Ponikowski P, Rakisheva A, Ristic A, Savarese G, Seferovic P, Sharma R, Tocchetti CG, Yilmaz MB, Vitale C, Volterrani M, von Haehling S, Chioncel O, Coats AJS, Rosano G. Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2023 Jun;25(6):776-791. doi: 10.1002/ejhf.2874. Epub 2023 May 19.

A37.            Temizhan A, Yilmaz MB. 2 Heart Failure Specialists Amid 2 Earthquakes 2 Decades Apart. JACC Heart Fail. 2023 Jun;11(6):715-716. doi: 10.1016/j.jchf.2023.03.015. Epub 2023 Apr 26.

A38.            Kocabay G, Kivrak T, Karaca O, Karasu M, Kaya H, Kanar B, Orscelik O, Kobat MA, Yilmaz MB. Effect of altitude on ticagrelor-induced dyspnea in patients with acute coronary syndrome. J Int Med Res. 2023 Apr;51(4):3000605211065932. doi: 10.1177/03000605211065932.

A39.           Berkan O, Kiziloğlu I, Keles E, Duman L, Bozkurt M, Adıbelli Z, Oncel G, Berkan N, Ekemen Keles Y, Jones JH, Inan AH, Solak C, Emiroğlu M, Yildirim M, Dursun A, Ilhan E, Camyar A, Inceer O, Nart A, Yilmaz MB. Does the Thymus Index Predict COVID-19 Severity? J Comput Assist Tomogr. 2022 Dec 29. doi: 10.1097/RCT.0000000000001425.

A40.           Çerik IB, Dindaş F, Yılmaz MB. Remember Diabetes Mellitus When Assessing Renal Blood Flow in Hypertensive Patients: A Renal Frame Count Study. Turk Kardiyol Dern Ars. 2023 Jan;51(1):32-39. English. doi: 10.5543/tkda.2022.77567.

A41.            Çetin Güvenç R, Güvenç TS, Temizhan A, Çavuşuğlu Y, Çelik A, Yılmaz MB. Effect of renal function on the prognostic importance of chloride in patients with heart failure. J Investig Med. 2023 Jan 20:10815589221149186. doi: 10.1177/10815589221149186.

A42.           Yildiz G, Hur E, Magden K, Candan F, Kayatas M, Yildirim İ, Yilmaz MB. A new technique for the detection of dry weight in hemodialysis patients: Estimated pulmonary capillary wedge pressure. A tissue Doppler imaging study. Nefrologia (Engl Ed). 2022 Jul-Aug;42(4):471-480. doi: 10.1016/j.nefroe.2021.04.008.

A43.           Çetin Güvenç R, Güvenç TS, Ural D, Çavuşoğlu Y, Yılmaz MB. Thrombolysis in Myocardial Infarction Risk Index Predicts One-Year Mortality in Patients with Heart Failure: An Analysis of the SELFIE-TR Study. Med Princ Pract. 2022 Sep 27. doi: 10.1159/000527214. Epub ahead of print.

A44.           Çavuşoğlu Y, Çelik A, Altay H, Nalbantgil S, Özden Ö, Temizhan A, Ural D, Ünlü S, Yılmaz MB, Zoghi M. Heart failure with non-reduced ejection fraction: Epidemiology, pathophysiology, phenotypes, diagnosis and treatment approaches. Turk Kardiyol Dern Ars. 2022 May;50(Supp1):S1-S34. doi: 10.5543/tkda.2022.S1.

A45.           Çavuşoğlu Y, Altay H, Aras D, Çelik A, Ertaş FS, Kılıçaslan B, Nalbantgil S, Temizhan A, Ural D, Yıldırımtürk Ö, Yılmaz MB. Cost-of-disease of Heart Failure in Turkey: A Delphi Panel-based Analysis of Direct and Indirect Costs. Balkan Med J. 2022 Jul 22;39(4):282-289.

A46.           Çavuşoğlu Y, Altay H, Nalbantgil S, Temizhan A, Yılmaz MB. Pre-Discharge and Post-Discharge Management and Treatment Optimization in Acute Heart Failure. Turk Kardiyol Dern Ars. 2022 Jul;50(5):378-394.

A47.           Bennis A, Ogola EN, Klug E, Skouri HN, Al Saffar HB, Ragy H, AlGhalayini KW, Alhumood KA, Abdelhamid M, Yilmaz MB, Tabbalat R, Çavuşoğlu Y. Strategic Recommendations to Bridge the Gaps in Awareness, Diagnosis and Prevention of Heart Failure in the Middle East Region and Africa. J Saudi Heart Assoc. 2022 Apr 15;34(1):53-65.

A48.           Solomon SD, Claggett BL, Miao ZM, Diaz R, Felker GM, McMurray JJV, Metra M, Corbalan R, Filippatos G, Goudev AR, Mareev V, Serpytis P, Suter T, Yilmaz MB, Zannad F, Kupfer S, Heitner SB, Malik FI, Teerlink JR. Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial. Eur Heart J. 2022 Jun 14;43(23):2212-2220.

A49.            Dindaş F, Güngör H, Ekici M, Akokay P, Erhan F, Doğduş M, Yılmaz MB. Reply to Letter to the Editor: "Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?". Anatol J Cardiol. 2022 Apr;26(4):344.

A50.           Çetin Güvenç R, Güvenç TS, Ural D, Çavuşoğlu Y, Yılmaz MB. Thrombolysis in Myocardial Infarction Risk Index Predicts One-Year Mortality in Patients with Heart Failure: An Analysis of the SELFIE-TR Study. Med Princ Pract. 2022 Sep 27. doi: 10.1159/000527214.

A51.           Jackson AM, Rørth R, Liu J, Kristensen SL, Anand IS, Claggett BL, Cleland JGF, Chopra VK, Desai AS, Ge J, Gong J, Lam CSP, Lefkowitz MP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rizkala AR, Rouleau JL, Seferović PM, Tromp J, Van Veldhuisen DJ, Yilmaz MB, Zannad F, Zile MR, Køber L, Petrie MC, Jhund PS, Solomon SD, McMurray JJV; PARAGON-HF Committees and Investigators. Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2021 Dec 17. doi:10.1002/ejhf.2403.

A52.           Desai AS, Vaduganathan M, Cleland JG, Claggett BL, Barkoudah E, Finn P, McCausland FR, Yilmaz MB, Lefkowitz M, Shi V, Pfeffer MA, McMurray JJV, Solomon SD. Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial. Circ Heart Fail. 2021 Dec;14(12):e008597. doi: 10.1161/CIRCHEARTFAILURE.121.008597.

A53.           Altay H, Çavuşoğlu Y, Çelik A, Demir Ş, Kılıçarslan B, Nalbantgil S, Temizhan A, Tokgöz B, Ural D, Yeşilbursa D, Yıldırımtürk Ö, Yılmaz MB. Management of Hyperkalemia in Heart Failure. Turk Kardiyol Dern Ars. 2021 Oct;49(Supp1):1-32. doi: 10.5543/tkda.2021.S1.

A54.            Dindaş F, Güngör H, Ekici M, Akokay P, Erhan F, Doğduş M, Yılmaz MB. Angiotensin receptor-neprilysin inhibition by sacubitril/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway. Anatol J Cardiol. 2021 Nov;25(11):821-828. doi: 10.5152/AnatolJCardiol.2021.356.

A55.           Vural S, Sayılan G, Şentürk B, Yılmaz MB, Çoşkun F. Women's representation in emergency medicine journals across two decades: 2000-2019. Am J Emerg Med. 2021 Dec;50:501-506. doi: 10.1016/j.ajem.2021.09.003.

A56.           Yilmaz MB. Does early angiography pave the way for improved outcomes in patients with acute heart failure? Eur Heart J. 2021 Sep 21;42(36):3767-3769. doi: 10.1093/eurheartj/ehab513.

A57.           Jackson AM, Jhund PS, Anand IS, Düngen HD, Lam CSP, Lefkowitz MP, Linssen G, Lund LH, Maggioni AP, Pfeffer MA, Rouleau JL, Saraiva JFK, Senni M, Vardeny O, Wijkman MO, Yilmaz MB, Saito Y, Zile MR, Solomon SD, McMurray JJV. Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. Eur Heart J. 2021 Aug 15:ehab499. doi: 10.1093/eurheartj/ehab499. Online ahead of print.

A58.           Murat S, Kaya H, Çavuşoğlu Y, Yılmaz MB. Hyperkalemia in chronic heart failure with renal dysfunction or diabetes mellitus: Results from the TREAT HF study. Turk Kardiyol Dern Ars. 2021 Apr;49(3):198-205. doi: 10.5543/tkda.2021.58675. PMID: 33847269.

A59.           Senturk B, Kaya H, Celik A, Bekar L, Gungor H, Zoghi M, Ural D, Cavusoglu Y, Temizhan A, Yilmaz MB. Marital status and outcomes in chronic heart failure: Does it make a difference of being married, widow or widower? North Clin Istanb. 2021 Jan 29;8(1):63-70. doi: 10.14744/nci.2020.88003.

A60.           Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Adams KF, Anand I, Arias-Mendoza A, Biering-Sørensen T, Böhm M, Bonderman D, Cleland JGF, Corbalan R, Crespo-Leiro MG, Dahlström U, Echeverria LE, Fang JC, Filippatos G, Fonseca C, Goncalvesova E, Goudev AR, Howlett JG, Lanfear DE, Li J, Lund M, Macdonald P, Mareev V, Momomura SI, O'Meara E, Parkhomenko A, Ponikowski P, Ramires FJA, Serpytis P, Sliwa K, Spinar J, Suter TM, Tomcsanyi J, Vandekerckhove H, Vinereanu D, Voors AA, Yilmaz MB, Zannad F, Sharpsten L, Legg JC, Varin C, Honarpour N, Abbasi SA, Malik FI, Kurtz CE; GALACTIC-HF Investigators. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure. N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797

A61.           Kilicaslan B, Unal B, Coskun MS, Zeren G, Ekin T, Ozcan S, Erdogan S, Ozdemir E, Deniz O, Ertas F, Karabay CY, Kaya D, Okuyan E, Barcin C, Nazli C, Kurt İH, Yilmaz MB. Post transcatheter aortic valve replacement ejection fraction response is predictor of survival among patients with whole range of systolic dysfunction. Acta Cardiol. 2020 Nov 4:1-11. doi: 10.1080/00015385.2020.1843853

A62.           Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Adams KF, Anand I, Arias-Mendoza A, Biering-Sørensen T, Böhm M, Bonderman D, Cleland JGF, Corbalan R, Crespo-Leiro MG, Dahlström U, Diaz R, Echeverria Correa LE, Fang JC, Filippatos G, Fonseca C, Goncalvesova E, Goudev AR, Howlett JG, Lanfear DE, Lund M, Macdonald P, Mareev V, Momomura SI, O'Meara E, Parkhomenko A, Ponikowski P, Ramires FJA, Serpytis P, Sliwa K, Spinar J, Suter TM, Tomcsanyi J, Vandekerckhove H, Vinereanu D, Voors AA, Yilmaz MB, Zannad F, Sharpsten L, Legg JC, Abbasi SA, Varin C, Malik FI, Kurtz CE; GALACTIC-HF Investigators. Omecamtiv Mecarbil in Chronic Heart Failure with Reduced Ejection Fraction, GALACTIC-HF: Baseline Characteristics and Comparison with Contemporary Clinical Trials. Eur J Heart Fail. 2020 Sep 27. doi: 10.1002/ejhf.2015. Epub ahead of print.

A63.           Kaya H, Şahin A, Güneş H, Bekar L, Çelik A, Çavuşoğlu Y, Çaldır V, Güngör H, Yılmaz MB. Increased frequency of occurrence of bendopnea is associated with poor outcomes in heart failure outpatients. Acta Cardiol. 2020 Aug 19:1-9. doi: 10.1080/00015385.2020.1797303. Epub ahead of print.

A64.           Robinson EL, Gomes CPDC, Potočnjak I, Hellemans J, Betsou F, de Gonzalo-Calvo D, Stoll M, Yilmaz MB, Ágg B, Beis D, Carmo-Fonseca M, Enguita FJ, Dogan S, Tuna BG, Schroen B, Ammerlaan W, Kuster GM, Carpusca I, Pedrazzini T, Emanueli C, Martelli F, Devaux Y. A Year in the Life of the EU-CardioRNA COST Action: CA17129 Catalysing Transcriptomics Research in Cardiovascular Disease. Noncoding RNA. 2020 May 18;6(2):17. doi: 10.3390/ncrna6020017.

A65.           Harjola VP, Parissis J, Bauersachs J, Brunner-La Rocca HP, Bueno H, Čelutkienė J, Chioncel O, Coats AJS, Collins SP, de Boer RA, Filippatos G, Gayat E, Hill L, Laine M, Lassus J, Lommi J, Masip J, Mebazaa A, Metra M, Miró Ò, Mortara A, Mueller C, Mullens W, Peacock WF, Pentikäinen M, Piepoli MF, Polyzogopoulou E, Rudiger A, Ruschitzka F, Seferovic P, Sionis A, Teerlink JR, Thum T, Varpula M, Weinstein JM, Yilmaz MB. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 Apr 29. doi:10.1002/ejhf.1831. Epub ahead of print.

A66.           Yılmaz MB, Aksakal E, Aksu U, Altay H, Nesligül Y, Çelik A, Akil MA, Bekar L, Vural MG, Çetin Güvenç R, Özer S, Ural D, Çavuşoğlu Y, Tokgözoğlu L. Snapshot evaluation of acute and chronic heart failure in real-life in Turkey: A follow-up data for mortality. Anatol J Cardiol. 2020 Feb;23(3):160-168. doi:10.14744/AnatolJCardiol.2019.87894.

A67.           Şimşek-Yavuz S, Akar AR, Aydoğdu S, Berzeg Deniz D, Demir H, Hazırolan T, Ozatik MA, Özer N, Sargın M, Topçuoğlu N, Turhan N, Yılmaz MB, Azap Ö, Başaran S, Çağ Y, Çağatay AA, Çınar Aydın G, Doğan Kaya S, Hızmalı L, Işık ME, Kılıçaslan N, Menekşe Ş, Meriç-Koç M, Öztürk S, Şensoy A, Tezer-Tekçe Y, Tükenmez-Tigen E, Uygun-Kızmaz Y, Velioğlu-Öcalmaz MŞ, Yeşilkaya A, Yılmaz E, Yılmaz N, Yılmaz-Karadağ F. Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019. Turk Kardiyol Dern Ars. 2020 Mar;48(2):187-226. English. doi: 10.5543/tkda.2020.89689.

A68.           Rørth R, Jhund PS, Yilmaz MB, Kristensen SL, Welsh P, Desai AS, Køber L, Prescott MF, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Circ Heart Fail. 2020 Feb;13(2):e006541. doi: 10.1161/CIRCHEARTFAILURE.119.006541.

A69.           Lainščak M, Milinković I, Polovina M, Crespo-Leiro MG, Lund LH, Anker SD, Laroche C, Ferrari R, Coats AJS, McDonagh T, Filippatos G, Maggioni AP, Piepoli MF, Rosano GMC, Ruschitzka F, Simić D, Ašanin M, Eicher JC, Yilmaz MB, Seferović PM; European Society of Cardiology Heart Failure Long-Term Registry Investigators Group. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry. Eur J Heart Fail. 2020 Jan;22(1):92-102. doi:10.1002/ejhf.1645.

A70.           Yılmaz MB. Brain-derived neurotrophic factor in heart failure. Anatol J Cardiol. 2019 Nov;22(6):317-318. doi: 10.14744/AnatolJCardiol.2019.49393.

A71.           Farmakis D, Agostoni P, Baholli L, Bautin A, Comin-Colet J, Crespo-Leiro MG, Fedele F, García-Pinilla JM, Giannakoulas G, Grigioni F, Gruchała M, Gustafsson F, Harjola VP, Hasin T, Herpain A, Iliodromitis EK, Karason K, Kivikko M, Liaudet L, Ljubas-Maček J, Marini M, Masip J, Mebazaa A, Nikolaou M, Ostadal P, Põder P, Pollesello P, Polyzogopoulou E, Pölzl G, Tschope C, Varpula M, von Lewinski D, Vrtovec B, Yilmaz MB, Zima E, Parissis J. A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus. Int J Cardiol. 2019 Dec 15;297:83-90.

A72.           Pollesello P, Ben Gal T, Bettex D, Cerny V, Comin-Colet J, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Harjola VP, Herpain A, Heringlake M, Heunks L, Husebye T, Ivancan V, Karason K, Kaul S, Kubica J, Mebazaa A, Mølgaard H, Parissis J, Parkhomenko A, Põder P, Pölzl G, Vrtovec B, Yilmaz MB, Papp Z. Short-Term Therapies for Treatment of Acute and Advanced Heart Failure-Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline? J Clin Med. 2019 Nov 1;8(11). pii: E1834. doi: 10.3390/jcm8111834.

A73.           Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Voors AA, Adams KF, Anker SD, Arias-Mendoza A, Avendaño P, Bacal F, Böhm M, Bortman G, Cleland JGF, Cohen-Solal A, Crespo-Leiro MG, Dorobantu M, Echeverría LE, Ferrari R, Goland S, Goncalvesová E, Goudev A, Køber L, Lema-Osores J, Levy PD, McDonald K, Manga P, Merkely B, Mueller C, Pieske B, Silva-Cardoso J, Špinar J, Squire I, Stępińska J, Van Mieghem W, von Lewinski D, Wikström G, Yilmaz MB, Hagner N, Holbro T, Hua TA, Sabarwal SV, Severin T, Szecsödy P, Gimpelewicz C; RELAX-AHF-2 Committees Investigators. Effects of Serelaxin in Patients with Acute Heart Failure. N Engl J Med. 2019 Aug 22;381(8):716-726.

A74.           Solomon SD, Rizkala AR, Lefkowitz MP, Shi VC, Gong J, Anavekar N, Anker SD, Arango JL, Arenas JL, Atar D, Ben-Gal T, Boytsov SA, Chen CH, Chopra VK, Cleland  J, Comin-Colet J, Duengen HD, Echeverría Correa LE, Filippatos G, Flammer AJ, Galinier M, Godoy A, Goncalvesova E, Janssens S, Katova T, Køber L, Lelonek M, Linssen G, Lund LH, O'Meara E, Merkely B, Milicic D, Oh BH, Perrone SV, Ranjith N, Saito Y, Saraiva JF, Shah S, Seferovic PM, Senni M, Sibulo AS Jr, Sim D, Sweitzer NK, Taurio J, Vinereanu D, Vrtovec B, Widimský J Jr, Yilmaz MB, Zhou J,  Zweiker R, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJV. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial. Circ Heart Fail. 2018 Jul;11(7):e004962. doi: 10.1161/CIRCHEARTFAILURE.118.004962.

A75.           Yılmaz MB. Heart rate in heart failure with mid-range ejection fraction. Anatol J Cardiol. 2018 Dec 6. doi: 10.14744/AnatolJCardiol.2018.56324. [Epub ahead of print] PubMed PMID: 30520430.

A76.           Çelik A, Altay H, Azap A, Çavuşoğlu Y, Nalbantgil S, Şenol E, Temizhan A, Yılmaz MB. Vaccination of adults with heart failure and chronic heart conditions: Expert opinion. Turk Kardiyol Dern Ars. 2018 Dec;46(8):723-734.

A77.           Maack C, Eschenhagen T, Hamdani N, Heinzel FR, Lyon AR, Manstein DJ, Metzger J, Papp Z, Tocchetti CG, Yilmaz MB, Anker SD, Balligand JL, Bauersachs J, Brutsaert D, Carrier L, Chlopicki S, Cleland JG, de Boer RA, Dietl A, Fischmeister R, Harjola VP, Heymans S, Hilfiker-Kleiner D, Holzmeister J, de Keulenaer G, Limongelli G, Linke WA, Lund LH, Masip J, Metra M, Mueller C, PieskeB, Ponikowski P, Ristic A, Ruschitzka F, Seferovic PM, Skouri H, Zimmermann WH, Mebazaa A. Treatments targeting inotropy. Eur Heart J. 2018 Oct 8. doi: 10.1093/eurheartj/ehy600.

A78.           Kayikcioglu M, Tokgozoglu L, Dogan V, Ceyhan C, Tuncez A, Kutlu M, Onrat E, Alici G, Akbulut M, Celik A, Yesilbursa D, Sahin T, Sonmez A, Ozdogan O, Temizhan A, Kilic S, Bayram F, Sabuncu T, Coskun FY, Ildizli M, Durakoglugil E, Kirilmaz B, Yilmaz MB, Yigit Z, Yildirim AB, Gedikli O, Topcu S, Oğuz A, Demir M, Yenerçağ M, Yıldırır A, Demircan S, Yilmaz M, Kaynar LG, Aktan M, Durmus RB, Gokce C, Ozcebe Oİ, Akyol TK, Okutan H, Sag S, Gul OO, Salcioglu Z, Altunkeser BB, Kuku I, Yasar HY, Kurtoglu E, Kose MD, Demircioglu S, Pekkolay Z, Ilhan O, Can LH. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)? Atherosclerosis. 2018 Oct;277:341-346.

A79.           Özer N, Kılıçkap M, Tokgözoğlu L, Göksülük H, Karaaslan D, Kayıkçıoğlu M, Yılmaz MB, Barçın C, Abacı A, Şahin M. Data on smoking in Turkey: Systematic review, meta-analysis and meta-regression of epidemiological studies on cardiovascular risk factors. Turk Kardiyol Dern Ars. 2018 Oct;46(7):602-612.

A80.           Abacı A, Kılıçkap M, Göksülük H, Karaaslan D, Barçın C, Kayıkçıoğlu M, Özer N, Yılmaz MB, Şahin M, Tokgözoğlu L. [Data on prevalence of metabolic syndrome in Turkey: Systematic review, meta-analysis and meta-regression of epidemiological studies on cardiovascular risk factors]. Turk Kardiyol Dern Ars. 2018 Oct;46(7):591-601.

A81.           Ural D, Kılıçkap M, Göksülük H, Karaaslan D, Kayıkçıoğlu M, Özer N, Barçın C, Yılmaz MB, Abacı A, Şengül Ş, Arınsoy T, Erdem Y, Sanisoğlu Y, Şahin M, Tokgözoğlu L. [Data on prevalence of obesity and waist circumference in Turkey: Systematic review, meta-analysis and meta regression of epidemiological studies on cardiovascular risk factors]. Turk Kardiyol Dern Ars. 2018 Oct;46(7):577-590.

A82.           Kayıkçıoğlu M, Tokgözoğlu L, Kılıçkap M, Göksülük H, Karaaslan D, Özer N, Abacı A, Yılmaz MB, Barçın C, Ateş K, Bayram F, Şahin M, Ural D. [Data on prevalence of dyslipidemia and lipid values in Turkey: Systematic review and meta-analysis of epidemiological studies on cardiovascular risk factors]. Turk Kardiyol Dern Ars. 2018 Oct;46(7):556-574.

A83.           Yılmaz MB, Kılıçkap M, Abacı A, Barçın C, Bayram F, Karaaslan D, Göksülük H, Kayıkçıoğlu M, Özer N, Süleymanlar G, Şahin M, Tokgözoğlu L, Satman İ. [Temporal  changes in the epidemiology of diabetes mellitus in Turkey: A systematic review and meta-analysis]. Turk Kardiyol Dern Ars. 2018 Oct;46(7):546-555.

A84.           Kılıçkap M, Barçın C, Göksülük H, Karaaslan D, Özer N, Kayıkçıoğlu M, Ural D, Yılmaz MB, Abacı A, Arıcı M, Altun B, Tokgözoğlu L, Şahin M. [Data on prevalence of hypertension and blood pressure in Turkey: Systematic review, meta-analysis and meta-regression of epidemiological studies on cardiovascular risk factors]. Turk Kardiyol Dern Ars. 2018 Oct;46(7):525-545.

A85.           Solomon SD, Rizkala AR, Lefkowitz MP, Shi VC, Gong J, Anavekar N, Anker SD, Arango JL, Arenas JL, Atar D, Ben-Gal T, Boytsov SA, Chen CH, Chopra VK, Cleland  J, Comin-Colet J, Duengen HD, Echeverría Correa LE, Filippatos G, Flammer AJ, Galinier M, Godoy A, Goncalvesova E, Janssens S, Katova T, Køber L, Lelonek M, Linssen G, Lund LH, O'Meara E, Merkely B, Milicic D, Oh BH, Perrone SV, Ranjith N, Saito Y, Saraiva JF, Shah S, Seferovic PM, Senni M, Sibulo AS Jr, Sim D, Sweitzer NK, Taurio J, Vinereanu D, Vrtovec B, Widimský J Jr, Yilmaz MB, Zhou J,  Zweiker R, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJV. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial. Circ Heart Fail. 2018 Jul;11(7):e004962. doi: 10.1161/CIRCHEARTFAILURE.118.004962.

A86.           Bildirici AE, Arslan S, Özbilüm Şahin N, Berkan Ö, Beton O, Yilmaz MB. MicroRNA-221/222 expression in atherosclerotic coronary artery plaque versus internal mammarian artery and in peripheral blood samples. Biomarkers. 2018 Jun 26:1-6. doi: 10.1080/1354750X.2018.1474260. [Epub ahead of print]

A87.           Cavusoglu Y, Kaya H, Eraslan S, Yilmaz MB. Hyponatremia is associated with occurrence of atrial fibrillation in outpatients with heart failure and reduced ejection fraction. Hellenic J Cardiol. 2018 Apr 3. pii: S1109-9666(17)30632-2.

A88.            Cheung A, Gong M, Bellanti R, Ali-Hasan-Al-Saegh S, Li G, Roig E, Núñez J, Stamos TD, Yilmaz MB, Hakki K, Wu WKK, Wong SH, Wong WT, Bazoukis G, Lampropoulos K, Tse LA, Zhao J, Lip GYH, Baranchuk A, Wong MCS, Liu T, Tse G. Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis. Heart Asia. 2018 Jan 7;10(1):e010970.

A89.           Doehner W, Ural D, Haeusler KG, Čelutkienė J, Bestetti R, Cavusoglu Y, Peña-Duque MA, Glavas D, Iacoviello M, Laufs U, Alvear RM, Mbakwem A, Piepoli MF, Rosen SD, Tsivgoulis G, Vitale C, Yilmaz MB, Anker SD, Filippatos G, Seferovic P, Coats AJS, Ruschitzka F. Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association. Eur J Heart Fail. 2018 Feb;20(2):199-215.

A90.           Dogan I, Dogan T, Yetim M, Kayadibi H, Yilmaz MB, Eser B, Kalcik M, Karavelioglu Y. Relation of Serum ADMA, Apelin-13 and LOX-1 Levels with Inflammatory and Echocardiographic Parameters in Hemodialysis Patients. Ther Apher Dial. 2018 Apr;22(2):109-117.

A91.           Kaymaz C, Mutlu B, Küçükoğlu MS, Kaya B, Akdeniz B, Kılıçkıran Avcı B, Aksakal E, Akbulut M, Atılgan Arıtürk Z, Güllülü S, Aydoğdu Taçoy G, Kayıkçıoğlu M, Nalbantgil S, Örem C, Erer HB, Yüce M, Ermiş N, Tüfekçioğlu O, Demir M, Yılmaz MB, Güngör Kaya M, Kültürsay H, Öngen Z, Tokgözoğlu L. Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG). Anatol J Cardiol. 2017 Oct;18(4):242-250.

A92.           Laribi S, Pemberton CJ, Kirwan L, Nouira S, Turkdogan K, Yilmaz MB, Troughton RW, Gayat E, Rivas-Lasarte M, Sadoune M, Sabti Z, Hansconrad E, Motiejunaite J, Plaisance P, Beshiri A, Chen W, Collet C, FitzGerald JM, Mueller C, Launay JM, Richards M, Mebazaa A; GREAT (Global Research on Acute Conditions Team) Network.  Mortality and acute exacerbation of COPD: a pilot study on the influence of myocardial injury. Eur Respir J. 2017 Jun 29;49(6).

A93.           Harjola VP, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca HP, Chioncel O, Collins SP, Doehner W, Filippatos GS, Flammer AJ, Fuhrmann V, Lainscak M, Lassus J, Legrand M, Masip J, Mueller C, Papp Z, Parissis J, Platz E, Rudiger A, Ruschitzka F, Schäfer A, Seferovic PM, Skouri H, Yilmaz MB, Mebazaa A. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2017 Jul;19(7):821-836.

A94.           Beton O, Kaya H, Kandemir O, Alibazoglu B, Alibazoglu H, Karabey E, Turgut OO, Yilmaz MB. The value of exercise SPET for the detection of coronary artery steal  syndrome secondary to unligated major side branch of left internal mammary artery. Hell J Nucl Med. 2016 Nov 8. pii: s002449910401. [Epub ahead of print]

A95.           Farmakis D, Alvarez J, Gal TB, Brito D, Fedele F, Fonseca C, Gordon AC, Gotsman I, Grossini E, Guarracino F, Harjola VP, Hellman Y, Heunks L, Ivancan V, Karavidas A, Kivikko M, Lomivorotov V, Longrois D, Masip J, Metra M, Morelli A, Nikolaou M, Papp Z, Parkhomenko A, Poelzl G, Pollesello P, Ravn HB, Rex S, Riha H, Ricksten SE, Schwinger RH, Vrtovec B, Yilmaz MB, Zielinska M, Parissis J. Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper. Int J Cardiol. 2016 Nov 1;222:303-12. doi: 10.1016/j.ijcard.2016.07.202. Review.

A96.           Beton O, Kaplanoglu H, Hekimoglu B, Yilmaz MB. Anatomic assessment of the left main bifurcation and dynamic bifurcation angles using computed tomography angiography. Folia Morphol (Warsz). 2016 Oct 7. doi: 10.5603/FM.a2016.0059.

A97.           Badoz M, Arrigo M, Iung B, Amioglu G, Yilmaz MB, Meneveau N, Sadoune M, Brunette A, Mebazaa A, Seronde MF. Role of cardiovascular biomarkers for the assessment of mitral stenosis and its complications. Eur J Intern Med. 2016 Oct;34:58-62.

A98.           Rossignol P, Legrand M, Kosiborod M, Hollenberg SM, Peacock WF, Emmett M, Epstein M, Kovesdy CP, Yilmaz MB, Stough WG, Gayat E, Pitt B, Zannad F, Mebazaa A. Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future. Pharmacol Res. 2016 Sep 29;113(Pt A):585-591.

A99.           Beton O, Asarcikli LD, Sen T, Ipek EG, Kafes H, Yaman M, Efe TH, Kaya H, Temizhan A, Yilmaz MB. Right Ventricular Dysfunction Complicates Time in Therapeutic Range in Heart Failure Patients Receiving Warfarin. Pharmacology. 2016 Sep 22;99(1-2):19-26.

A100.       Senni M, McMurray JJ, Wachter R, McIntyre HF, Reyes A, Majercak I, Andreka P, Shehova-Yankova N, Anand I, Yilmaz MB, Gogia H, Martinez-Selles M, Fischer S, Zilahi Z, Cosmi F, Gelev V, Galve E, Gómez-Doblas JJ, Nociar J, Radomska M, Sokolova B, Volterrani M, Sarkar A, Reimund B, Chen F, Charney A. Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens. Eur J Heart Fail. 2016 Sep;18(9):1193-202.

A101.       Zoghi M, Kaya H, Çavuşoğlu Y, Aksakal E, Demir Ş, Yücel C, Mutlu H, Ergene O, Yılmaz MB; Beta GenTURK Study.. Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients:The Beta GenTURK study. Turk Kardiyol Dern Ars. 2016 Sep;44(6):457-65.

A102.       Beton O, Saricam E, Kaya H, Yucel H, Dogdu O, Turgut OO, Berkan O, Tandogan I, Yilmaz MB. Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid? BMC Cardiovasc Disord. 2016 Apr 22;16:73.

A103.       Kaya H, Coşkun A, Beton O, Zorlu A, Kurt R, Yucel H, Gunes H, Yılmaz MB.Carboxyhemoglobin levels predict the long-term development of acute myocardial infarction in carbon monoxide poisoning. Am J Emerg Med. 2016 Feb 12. doi: 10.1016/j.ajem.2016.01.036. [Epub ahead of print]

A104.       Kaya H, Zorlu A, Yucel H, Tatlisu MA, Kivrak T, Coskun A, Yilmaz MB. Higher cancer antigen 125 level is associated with the presence of permanent atrial fibrillation in systolic heart failure patients. Acta Cardiol. 2016 Feb;71(1):61-6.

A105.       Beton O, Efe TH, Kaya H, Bilgin M, Dinc Asarcikli L, Yilmaz MB. Electrical Injury-Induced Complete Atrioventricular Block: Is Permanent Pacemaker Required? Case Rep Cardiol. 2015;2015:158948. doi: 10.1155/2015/158948.

A106.       Kaya H, Beton O, Yilmaz MB. How to increase level of patients' awareness regarding the importance of statins despite the influence of the media? Int J Cardiol. 2016 Mar 15;207:164.

A107.       Kaya H, Beton O, Yilmaz MB. Atrial fibrillation and D dimer levels for patients with acute decompensated heart failure. Int J Cardiol. 2016 Mar 15;207:136.

A108.       Hayta E, Yılmaz MB, Yayıkçı İ, Özer Z, Şahin Ö. Is There a Clinically Meaningful Change in the Blood Pressure of Osteoarthritis Patients with Comorbid  Hypertension During the Course of Balneotherapy? N Am J Med Sci. 2015 Nov;7(11):517-23.

A109.       Beton O, Kaplanoğlu H, Berkan Ö, Yılmaz MB. A Case Report of Delayed Diagnosed Chronic Aortocaval Fistula: A Rare Complication of Penetrating Trauma to the Abdomen. J Clin Imaging Sci. 2015 Nov 30;5:62.

A110.       Korkmaz O, Yucel H, Zorlu A, Berkan O, Kaya H, Goksel S, Beton O, Yilmaz MB. Elevated gamma glutamyl transferase levels are associated with the location of acute pulmonary embolism. Cross-sectional evaluation in hospital setting. Sao Paulo Med J. 2015 Dec;133(6):488-94.

A111.        Yücel H, Zorlu A, Kaya H, Yılmaz MB. Regular blood donation improves endothelial function in adult males. Anatol J Cardiol. 2015 Apr 30. doi:10.5152/akd.2015.6093. [Epub ahead of print]

A112.       Çavuşoğlu Y, Altay H, Ekmekçi A, Eren M, Küçükoğlu MS, Nalbantgil S, Sarı İ, Selçuk T, Temizhan A, Ural D, Weinstein JM, Yeşilbursa D, Yılmaz MB, Zoghi M, Aydoğdu S, Kutlu M, Özer N, Şahin M, Tokgözoğlu L. Practical approaches for the treatment of chronic heart failure: Frequently asked questions, overlooked points and controversial issues in current clinical practice. Anatol J Cardiol. 2015 Oct;15 Suppl 2:1-60. doi: 10.5152/AnatolJCardiol.2015.6767.

A113.       Ural D, Çavuşoğlu Y, Eren M, Karaüzüm K, Temizhan A, Yılmaz MB, Zoghi M, Ramassubu K, Bozkurt B. Diagnosis and management of acute heart failure. Anatol J Cardiol. 2015 Nov;15(11):860-89. doi: 10.5152/AnatolJCardiol.2015.6567.

A114.       Mebazaa A, Tolppanen H, Mueller C, Lassus J, DiSomma S, Baksyte G, Cecconi M, Choi DJ, Cohen Solal A, Christ M, Masip J, Arrigo M, Nouira S, Ojji D, Peacock F, Richards M, Sato N, Sliwa K, Spinar J, Thiele H, Yilmaz MB, Januzzi J. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive Care Med. 2016 Feb;42(2):147-63

A115.       Çavuşoğlu Y, Korkmaz Ş, Demirtaş S, Gencer E, Şaşmaz H, Mutlu F, Güneş H, Mert UK, Özdemir S, Kalaycı S, Yılmaz MB. Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study. Anatol J Cardiol. 2015;15(8):611-7. doi: 10.5152/akd.2015.6156.

A116.       Yücel H, Refiker Ege M, Zorlu A, Kaya H, Beton O, Güngör H, Acar G, Temizhan A, Çavuşoğlu Y, Zoghi M, Eren M, Ural D, Yılmaz MB. Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction. Turk Kardiyol Dern Ars. 2015;43(5):427-33.

A117.       Mebazaa A, Yilmaz MB, Levy P, Ponikowski P, Peacock WF, Laribi S, Ristic AD, Lambrinou E, Masip J, Riley JP, McDonagh T, Mueller C, deFilippi C, Harjola VP, Thiele H, Piepoli MF, Metra M, Maggioni A, McMurray JJ, Dickstein K, Damman K, Seferovic PM, Ruschitzka F, Leite-Moreira AF, Bellou A, Anker SD, Filippatos G. Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine - short version. Eur Heart J. 2015 ;36(30):1958-66

A118.       Kaya H, Zorlu A, Yucel H, Dogan OT, Sarikaya S, Aydin G, Kivrak T, Yilmaz MB. Cancer antigen-125 levels predict long-term mortality in chronic obstructive pulmonary disease. Biomarkers. 2015 May 19:1-6. [Epub ahead of print]

A119.       Varol K, Gumus C, Yucel H, Sezer F, Seker E, Inci MF, Yucel S, Kaya H, Berk S, Yilmaz MB. Correlation of right ventricular dysfunction on acute pulmonary embolism with pulmonary artery computed tomography obstruction index ratio (PACTOIR) and comparison with echocardiography. Jpn J Radiol. 2015 Apr 18. [Epub ahead of print]

A120.       Patti G, Bennett R, Seshasai SR, Cannon CP, Cavallari I, Chello M, Nusca A, Mega S, Caorsi C, Spadaccio C, Keun On Y, Mannacio V, Berkan O, Yilmaz MB, Katrancioglu N, Ji Q, Kourliouros A, Baran Ç, Pasceri V, Rüçhan Akar A, Carlos Kaski J, Di Sciascio G, Ray KK. Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials. Europace. 2015 Jun;17(6):855-63

A121.        Yücel H, Türkdoğan KA, Zorlu A, Aydın H, Kurt R, Yılmaz MB. Association between oxidative stress index and post-CPR early mortality in cardiac arrest patients: A prospective observational study. Anadolu Kardiyol Derg. 2014 Oct 15.doi: 10.5152/akd.2014.5719. [Epub ahead of print]

A122.       Yılmaz MB. How will 2014 European Society of Cardiology Congress influence our daily practice? Anadolu Kardiyol Derg. 2014 Dec;14(8):669-73.

A123.        Yucel H, Kaya H, Zorlu A, Yıldırımlı K, Sancakdar E, Gunes H, Kurt R, Ozgul U, Turgut OO, Yilmaz MB. Cancer antigen 125 levels and increased risk of new-onset atrial fibrillation. Herz. 2015 Apr;40(Supplement 2):119-124.

A124.       Guray Y, Ipek EG, Guray U, Demirkan B, Kafes H, Asarcikli LD, Cabuk G, Yilmaz MB. Red cell distribution width predicts mortality in infective endocarditis. Arch Cardiovasc Dis. 2014 May;107(5):299-307.

A125.       Semiz M, Yücel H, Kavakçı O, Yıldırım O, Zorlu A, Yılmaz MB, Küçükdurmaz Z, Canan F. Atypical antipsychotic use is an independent predictor for the increased mean platelet volume in patients with schizophrenia: A preliminary study. J Res Med Sci. 2013 ;18(7):561-6.

A126.       Yalta K, Yilmaz MB. Coronary microvascular dysfunction portends poor prognosis in the setting of chronic renal failure: Harnessing dual marker strategy for better risk-stratification? Int J Cardiol. 2014 ;171(2):275-6.

A127.       Russo V, Navarin S, Zampini G, Magrini L, Mann C, Muiesan ML, De Caterina R, Yılmaz MB, Beton O, Monzani V, Kubica J, Müller C, Di Somma S, On Behalf Of Great Network N. Management of atrial fibrillation in the Emergency Department: current approach and future expectations. Eur Rev Med Pharmacol Sci. 2013 ;17(23):3132-47.

A128.        Celik VK, Eken IE, Yildiz G, Yilmaz MB, Gurlek A, Aydin H. Vitamin E and antioxidant activity; its role in slow coronary flow. Cardiovasc J Afr. 2013 ;24(9-10):360-3.

A129.       5: Ege MR, Yilmaz MB. Heart failure and diuretic treatment. Minerva Cardioangiol. 2013 ;61(6):701.

A130.       Yılmaz MB, Nikolaou M, Mebazaa A. Cardiohepatic interactions in heart failure. Anadolu Kardiyol Derg. 2013 ;13(7):731-2.

A131.        Yilmaz MB, Grossini E, Silva Cardoso JC, Édes I, Fedele F, Pollesello P, Kivikko M, Harjola VP, Hasslacher J, Mebazaa A, Morelli A, le Noble J, Oldner A, Oulego Erroz I, Parissis JT, Parkhomenko A, Poelzl G, Rehberg S, Ricksten SE, Rodríguez Fernández LM, Salmenperä M, Singer M, Treskatsch S, Vrtovec B, Wikström G. Renal effects of levosimendan: a consensus report. Cardiovasc Drugs Ther. 2013 ;27(6):581-90.

A132.        Yildiz G, Kayataş M, Candan F, Yilmaz MB, Zorlu A, Sarikaya S. What Is the Meaning of Increased Myocardial Injury Enzymes during Hemodialysis? A Tissue Doppler Imaging Study. Cardiorenal Med. 2013 ;3(2):136-153.

A133.        Akkaya E, Vuruskan E, Zorlu A, Sincer I, Kucukosmanoglu M, Ardic I, Yilmaz MB. Aortic intracardiac echocardiography-guided septal puncture during mitral valvuloplasty. Eur Heart J Cardiovasc Imaging. 2014 ;15(1):70-6.

A134.       Zorkun C, Amioğlu G, Bektaşoğlu G, Zorlu A, Ekinözü İ, Turgut OO, Tandoğan İ, Yılmaz MB. Elevated mean pulmonary artery pressure in patients with mild-to-moderate mitral stenosis: a useful predictor of worsening renal functions? Anadolu Kardiyol Derg. 2013 ;13(5):457-64.

A135.       Ege MR, Zorlu A, Yilmaz MB, Acikgoz S, Tandogan I, Cinar Z. Central diastolic blood pressure is associated with the degree of coronary collateral development. Angiology. 2013 ;64(7):546-52.

A136.       Yılmaz MB. [After the 2012 Guidelines on heart failure of the European Society of Cardiology]. Turk Kardiyol Dern Ars. 2012 ;40(5):397-9.

A137.       Nikolaou M, Parissis J, Yilmaz MB, Seronde MF, Kivikko M, Laribi S, Paugam-Burtz C, Cai D, Pohjanjousi P, Laterre PF, Deye N, Poder P, Solal AC, Mebazaa A. Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. Eur Heart J. 2012 Oct 22. [Epub ahead of print]

A138.       Altay H, Zorlu A, Kocum HT, Demircan S, Yilmaz N, Yilmaz MB. Relationship between parathyroid hormone and depression in heart failure. Arq Bras Cardiol. 2012 Oct;99(4):915-23. Epub 2012 Sep 13. English, Portuguese.

A139.       Sen T, Aksu T, Yilmaz MB. Carbohydrate antigen-125 is a mirror of both left and right sides of the heart. Tex Heart Inst J. 2012;39(4):603-4.

A140.       Ege MR, Guray U, Guray Y, Yilmaz MB, Yucel O, Zorlu A, Tandogan I. Acute heart failure with accompanying chronic obstructive pulmonary disease: should we focus  on beta blockers? Herz. 2012 Nov;37(7):796-800.

A141.       Turkdogan KA, Zorlu A, Engin A, Guven FM, Polat MM, Turgut OO, Yilmaz MB. C-type natriuretic peptide is associated with the severity of Crimean-Congo hemorrhagic fever. Int J Infect Dis. 2012 Aug;16(8):e616-20. doi: 10.1016/j.ijid.2012.04.009. Epub 2012 Jun 12.

A142.       Ege MR, Yilmaz N, Yilmaz MB. Depression and heart failure. Int J Cardiol. 2012 Jul 26;158(3):474. doi: 10.1016/j.ijcard.2012.05.067

A143.       Zorlu A, Yücel H, Yontar OC, Karahan O, Tandogan I, Katrancioglu N, Yilmaz MB. Effect of levosimendan in patients with severe systolic heart failure and worsening renal function. Arq Bras Cardiol. 2012 May 29. pii:S0066-782X2012005000048. [Epub ahead of print] English, Portuguese.

A144. Turkdogan KA, Zorlu A, Guven FM, Ekinozu I, Eryigit U, Yilmaz MB. Usefulness of admission matrix metalloproteinase 9 as a predictor of early mortality after cardiopulmonary resuscitation in cardiac arrest patients. Am J Emerg Med. 2012 May 23. [Epub ahead of print]

A145. Altay H, Zorlu A, Bilgi M, Erol T, Yilmaz MB. Usefulness of parathyroid hormone as a predictor of heart failure with preserved ejection fraction. Biomarkers. 2012 May 15. [Epub ahead of print]

A146. Zorlu A, Yucel H, Bektasoglu G, Turkdogan KA, Eryigit U, Sarikaya S, Ege MR, Tandogan I, Yilmaz MB. Increased γ-glutamyl transferase levels predict early mortality in patients with acute pulmonary embolism. Am J Emerg Med. 2012 Feb 29. [Epub ahead of print]

A147. Comert N, Yucel O, Ege MR, Yaylak B, Erdogan G, Yilmaz MB. Echocardiographic Epicardial Adipose Tissue Predicts Subclinical Atherosclerosis: Epicardial adipose tissue and Atherosclerosis. Angiology. 2012 Jan 10. [Epub ahead of print]

A148. Korkmaz S, Demirkan B, Guray Y, Yilmaz MB, Sasmaz H. Long-term follow-up of iatrogenic atrial septal defect after percutaneous mitral balloon valvuloplasty. Tex Heart Inst J. 2011;38(5):523-7.

A149. Manduz S, Katrancioglu N, Karahan O, Yucel O, Yilmaz MB. Diagnosis and follow up of patients with primary cardiac tumours: a single-centre experience of myxomas. Cardiovasc J Afr. 2011;22(6):310-2.

A150. Zorlu A, Akkaya E, Altay H, Bektasoglu G, Turkdogan KA, Sincer I, Vuruskan E, Cınar Z, Tandogan I, Yilmaz MB. The relationship between D-dimer level and the development of atrial fibrillation in patients with systolic heart failure. J Thromb Thrombolysis. 2011 Dec 4. [Epub ahead of print]

A151. Aksu T, Yilmaz MB. Letter to the editor. Clin Ther. 2011 ;33(12):2089.

A152. Korkmaz S, Yilmaz MB, Sencan M. How to manage coronary slow flow following PCI? Int J Cardiol. 2011 Nov 15. [Epub ahead of print]

A153. Yilmaz MB, Gayat E, Salem R, Lassus J, Nikolaou M, Laribi S, Parissis J, Follath F, Peacock WF, Mebazaa A. Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis. Eur J Heart Fail. 2011 ;13(11):1244-52

A154. Ozyol A, Yucel O, Ege MR, Zorlu A, Yilmaz MB. Microalbuminuria is Associated With the Severity of Coronary Artery Disease Independently of Other Cardiovascular Risk Factors. Angiology. 2011 Oct 17. [Epub ahead of print]

A155. Sincer I, Zorlu A, Yilmaz MB, Dogan OT, Ege MR, Amioglu G, Aydin G, Ardic I, Tandogan I. Relationship between red cell distribution width and right ventricular dysfunction in patients with chronic obstructive pulmonary disease. Heart Lung. 2011 Oct 11. [Epub ahead of print]

A156. Altay H, Zorlu A, Binici S, Bilgi M, Yilmaz MB, Colkesen Y, Erol T, Muderrisoglu H. Relation of Serum Parathyroid Hormone Level to Severity of Heart Failure. Am J Cardiol. 2011 Oct 12. [Epub ahead of print]

A157. Zorlu A, Amioglu G, Yilmaz N, Semiz M, Refiker Ege M, Aydin G, Tandogan I, Yilmaz MB. The relationship between mean pulmonary artery pressure and quality of life in patients with mitral stenosis. Cardiology. 2011;119(3):170-5.

A158. Zorlu A, Bektasoglu G, Kukul Guven FM, Dogan OT, Gucuk E, Refiker Ege M, Altay H, Cınar Z, Tandogan I, Yilmaz MB. Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism. Am J Cardiol. 2012 ;109(1):128-34.

A159. Beton O, Yilmaz MB, Tandoğan I. Herbal remedies: science or tradition? The ethical dilemma. Intern Emerg Med. 2011 Sep 29. [Epub ahead of print]

A160. Yilmaz MB, Engin A, Bektasoglu G, Zorlu A, Ege MR, Bakir M, Dokmetas I. Does electrocardiography at admission predict outcome in Crimean -Congo hemorrhagic fever? J Vector Borne Dis. 2011 ;48(3):150-4.

A161. Zorlu A, Yilmaz MB, Yucel H, Bektasoglu G, Refiker Ege M, Tandogan I. Increased d-dimer levels predict cardiovascular mortality in patients with systolic heart failure. J Thromb Thrombolysis. 2011 Sep 8. [Epub ahead of print]

A162. Yilmaz MB, Mebazaa A. In vivo and in vitro evidence for pleiotropic effects of levosimendan in the intensive care setting. Crit Care. 2011 Aug 18;15(4):182.

A163. Korkmaz S, Demirkan B, Güray Y, Yılmaz MB, Aksu T, Saşmaz H. Acute and long-term follow-up results of percutaneous mitral balloon valvuloplasty: a single-center study. Anadolu Kardiyol Derg. 2011 Sep;11(6):515-20.

A164. Beton O, Yılmaz MB, Turgut O, Tandoğan I. Association of pro-inflammatory cytokines and T-cell activation marker with CA-125 levels in obese patients with  heart failure: implications for complex immunoinflammatory pathophysiology. Med Sci Monit. 2011 ;17(8):LE5-6.

A165. Papp Z, Edes I, Fruhwald S, De Hert SG, Salmenperä M, Leppikangas H, Mebazaa A, Landoni G, Grossini E, Caimmi P, Morelli A, Guarracino F, Schwinger RH, Meyer S, Algotsson L, Wikström BG, Jörgensen K, Filippatos G, Parissis JT, González MJ, Parkhomenko A, Yilmaz MB, Kivikko M, Pollesello P, Follath F. Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan. Int J Cardiol. 2011 Jul 23. [Epub ahead of print]

A166. Ege MR, Yucel O, Zorlu A, Yilmaz MB. Letter to editor: clinical profile and predictors of in-hospital outcome in patients with heart failure. Int J Cardiol. 2011 6;152(1):116

A167. Korkmaz Ş, Demirkan B, Altay H, Refiker Ege M, Çaldır V, Yılmaz MB, Güray Y, Güray Ü, Şaşmaz H. Serum creatinine is independently associated with angiographic extent of coronary artery disease in patients with stable angina pectoris. Anadolu Kardiyol Derg. 2011 ;11(5):407-13.

A168. Yilmaz MB, Nikolaou M, Cohen-Solal A. Tumour biomarkers in heart failure: is there a role for CA-125? Eur J Heart Fail 2011 ;13(6):579-83

A169. Ege M, Güray U, Güray Y, Yılmaz MB, Demirkan B, Saşmaz A, Korkmaz S. Relationship between TIMI frame count and admission glucose values in acute ST elevation myocardial infarction patients who underwent successful primary percutaneous intervention. Anadolu Kardiyol Derg. 2011 ;11(3):213-7.

A170. Ege MR, Yılmaz N, Yılmaz MB. Depression and perceptions about heart failure predict quality of life. Heart Lung. 2011; 40(6):585

A171. Yilmaz MB, Zorlu A, Dogan OT, Karahan O, Tandogan I, Akkurt I. Role of CA-125  in Identification of Right Ventricular Failure in Chronic Obstructive Pulmonary Disease. Clin Cardiol. 2011 ;34(4):244-8.

A172. Ege MR, Yılmaz MB, Guray Y. Cardiac cachexia and gastrointestinal system. Int J Cardiol. 2011; 149(2):245-6

A173. Zorlu A, Tandogan I, Yilmaz MB. CA-125, an omitted part of the heart. Heart Lung Circ. 2011; 20(5):345

A174. Ege MR, Zorlu A, Yılmaz MB. CA-125 and heart failure. Int J Cardiol. 2011;147(3):453-4.

A175. Katrancioglu N, Manduz S, Karahan O, Yilmaz MB, Sezgin I, Bagci G, Berkan O. The Role of the CCR2 Gene Polymorphism in Abdominal Aortic Aneurysms. Angiology. 2011 ;62(2):140-3.

A176. Follath F, Yilmaz MB, Delgado JF, Parissis JT, Porcher R, Gayat E, Burrows N, McLean A, Vilas-Boas F, Mebazaa A. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF). Intensive Care Med. 2011 ;37(4):619-26

A177.  Yontar OC, Yilmaz MB, Yalta K, Erdem A, Tandogan I. [Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure.]. Arq Bras Cardiol. 2010; 95(6):738-42

A178. Yalta K, Yilmaz MB, Yalta T, Sivri N, Yucel O. Coronary syndrome Y: Should we focus more on extra-cardiac conditions including renal disease and its management? Int J Cardiol. 2011 ;146(3):418

A179. Katrancioglu N, Manduz S, Ozen F, Yilmaz MB, Karahan O, Ozdemir O, Berkan O. Type I plasminogen activator inhibitor 4G allele frequency is associated with chronic venous insufficiency. J Int Med Res. 2010 ;38(4):1513-8.

A180. Yontar OC, Yilmaz MB, Yalta K, Tandoğan I. Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter? Anadolu Kardiyol Derg. 2010;10(4):310-6.

A181. Guray U, Ege M, Guray Y, Yilmaz MB. Ethnicity and medication adherence: factors that need to be taken into account. J Card Fail. 2010 ;16(7):619.

A182. Ege MR, Yilmaz MB. Should we resynchronize all left bundle branch blocks in patients presenting with acute heart failure? Int J Cardiol. 2011; 146(2):230.

A183.  Ege MR, Yilmaz N, Yilmaz MB. High mortality among heart failure patients treated with antidepressants. Int J Cardiol. 2011; 146(1):94.

A184. Turgut O, Tandogan I, Yilmaz MB, Gul I, Zorlu A. CA125 in heart failure: Implications for immunoinflammatory activity. Int J Cardiol. 2011; 146(1):99-100

A185. Yalta K, Yilmaz MB, Yalta T, Sivri N, Refiker M. Coronary slow flow: a potential prognostic marker correlating with the disease severity in renal failure? Nephrol Dial Transplant. 2010 ;25(9):3124;

A186. Yilmaz MB, Laribi S, Mebazaa A. Managing beta-blockers in acute heart failure: when to start and when to stop? Curr Heart Fail Rep. 2010 ;7(3):110-5. Review.

A187. Yontar OC, Yilmaz MB, Güray U. [ST-segment elevation in patients with acute myocardial infarction during a mean platelet volume of applications after fibrinolytic treatment effect on TIMI frame number]. Turk Kardiyol Dern Ars. 2010 ;38(2):149-50.

A188. Refiker M, Yilmaz MB. Association of right heart with CA-125 levels in patients with heart failure. Int J Cardiol. 2010; 145(3):521-2

A189. Salem R, Sibellas F, Socrates T, Arenja N, Yilmaz MB, Mueller C, Mebazaa A. Novelties in the early management of acute heart failure syndromes. Swiss Med Wkly. 2010 ;140:w13031.

A190. Yalta K, Yontar OC, Yilmaz MB, Erdem A, Turgut OO, Yilmaz A, Manduz S, Tandoğan I. Triple right coronary artery accompanied by an ectopic circumflex artery arising from right sinus of Valsalva. Anadolu Kardiyol Derg. 2010 15;10(1):E1.

A191.  Yilmaz MB, Mebazaa A. Searching for an ideal hemodynamic marker to predict short-term outcome in cardiogenic shock. Crit Care. 2009;13(6):1013.

A192. Yalta K, Yalta T, Turgut OO, Yılmaz MB, Tandogan I. Cytokines: Potential contributors to arrhythmogenesis in demyelinating syndromes? Int J Cardiol. 2011 7;146(1):90

A193. Yalta K, Turgut OO, Yilmaz MB, Yilmaz A, Tandogan I. Genetic basis of sudden cardiac death due to emotional trauma in apparently healthy individuals. Int J Cardiol. 2010; 145(3):518-9

A194. Yontar OC, Yalta K, Yilmaz MB. Superiority of levosimendan over dobutamine in right ventricle failure. Crit Care Med. 2010 ;38(1):342-3

A195. Yilmaz MB, Zorlu A, Tandogan I. Plasma CA-125 level is related to both sides of the heart: A retrospective analysis. Int J Cardiol. 2011; 149(1):80-2.

A196. Zoghi M, Cavuşoğlu Y, Yilmaz MB, Nalbantgil S, Eren M, Mebazaa A. [Practical approach to acute heart failure with algorithms]. Anadolu Kardiyol Derg. 2009 ;9(6):436-46. Turkish.

A197. Yontar OC, Yilmaz MB, Yalta K. Levosimendan in acute and chronic right ventricle failure. Acta Anaesthesiol Scand. 2010 ;54(1):118-9.

A198.  Katrancioglu N, Manduz S, Ozen F, Yilmaz MB, Atahan E, Ozdemir O, Berkan O. Association Between ApoE4 Allele and Deep Venous Thrombosis: A Pilot Study. Clin Appl Thromb Hemost. 2011 ;17(2):225-8

A199.  Yontar OC, Yilmaz MB. Relationship between high-density lipoprotein and the progression of aortic valvular disease. J Card Surg. 2009 ;24(5):533.

A200.  Yalta K, Yılmaz MB, Turgut OO, Tandogan I. Markers of inflammation and thrombin generation: Additional guides in determining the therapeutic strategy for malign ventricular arrhythmias after an acute myocardial infarction? Int J Cardiol. 2010;145(3):492-3

A201.  Yalta K, Yilmaz MB, Turgut OO, Tandogan I. Natriuretic peptides: Useful biomarkers in predicting the possibility of restoration and maintenance of sinus  rhythm in patients with atrial fibrillation undergoing cardioversion? Int J Cardiol. 2010 ;145(2):233

A202. Yalta K, Turgut OO, Yilmaz MB, Yilmaz A, Tandogan I. Dronedarone: a promising alternative for the management of atrial fibrillation. Cardiovasc Drugs Ther. 2009 ;23(5):385-93. Review.

A203. Kazanci D, Unver S, Karadeniz U, Iyican D, Koruk S, Yilmaz MB, Erdemli O. A comparison of the effects of desflurane, sevoflurane and propofol on QT, QTc, and P dispersion on ECG. Ann Card Anaesth. 2009 ;12(2):107-12

A204. Karaeren H, Yokuşoğlu M, Uzun S, Baysan O, Köz C, Kara B, Kirilmaz A, Naharci I, Pinar M, Yilmaz MB, Uzun M. The effect of the content of the knowledge on adherence to medication in hypertensive patients. Anadolu Kardiyol Derg. 2009 ;9(3):183-8.

A205. Yontar OC, Erdem A, Yilmaz MB. Sleep quality in patients with hypertension: additional negative effect of drug therapy. Sleep Med. 2009 ;10(10):1168

A206. Erdem A, Yontar OC, Yilmaz MB. Detecting posterior wall acute myocardial infarction by electrocardiogram. Am J Cardiol. 2009 ;103(11):1622.

A207. Yilmaz MB, Yalta K. Coronary flow slows as renal function worsens. Clin Cardiol. 2009 ;32(5):278-82.

A208. Turgut O, Tandogan I, Yilmaz MB, Gul I, Gurlek A. CA125 levels among patients with advanced heart failure: An emerging independent predictor for survival. Int J Cardiol. 2010 ;145(1):71.

A209. Yontar OC, Yilmaz MB. Lipoprotein levels and the progression of aortic valvular disease. Heart. 2009 Jun;95(11):938;

A210.  Uzun S, Kara B, Yokuşoğlu M, Arslan F, Yilmaz MB, Karaeren H. The assessment of adherence of hypertensive individuals to treatment and lifestyle change recommendations. Anadolu Kardiyol Derg. 2009 ;9(2):102-9.

A211. Turgut O, Tandogan I, Yilmaz MB, Yalta K, Aydin O. Association of P wave duration and dispersion with the risk for atrial fibrillation: practical considerations in the setting of coronary artery disease. Int J Cardiol. 2010 ;144(2):322-4

A212. Berkan O, Katrancioglu N, Ozker E, Ozerdem G, Bakici Z, Yilmaz MB. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery. Thorac Cardiovasc Surg. 2009 ;57(2):91-5

A213. Yilmaz MB, Yontar C, Erdem A, Karadas F, Yalta K, Turgut OO, Yilmaz A, Tandogan I. Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure. Heart Vessels. 2009 ;24(1):16-21.

A214. Turgut O, Yalta K, Yilmaz MB, Dizman R, Tandogan I. Free-floating biatrial thrombi with concomitant saddle pulmonary embolism. Int J Cardiol. 2009; 144(1):11-3

A215.  Yontar OC, Yalta K, Yilmaz MB, Turgut OO. Short QT syndrome: a very rare arrhythmogenic entity. Acta Cardiol. 2008 ;63(5):553-5.

A216. Turgut O, Tandogan I, Yalta K, Yilmaz MB, Dizman R. Geodesic pattern of coronary arteries as a predictor for cardiovascular risk: Clinical perspectives. Int J Cardiol.  2010 ;142(3):e38-9

A217. Engin A, Yilmaz MB, Elaldi N, Erdem A, Yalta K, Tandogan I, Kaya S, Bakir M, Dokmetas I.  Crimean-Congo hemorrhagic fever: does it involve the heart? Int J Infect Dis. 2009; 13(3):369-73

A218. Yilmaz MB, Yontar OC.  Smoker's paradox in heart failure: might asymmetric dimethylarginine be the possible explanation? Eur Heart J. 2008 ; 29(23):2948-9; author reply 2949.

A219. Yontar OC, Yilmaz MB.  Importance of serum high-density lipoprotein levels to aortic valvular disease. Br J Pharmacol. 2008 ;155(8):1163.

A220. Yilmaz MB, Erdem A, Yalta K, Turgut OO, Yilmaz A, Tandogan I.  Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol. Adv Ther. 2008 ;25(9):871-83.

A221. Turgut O, Yilmaz MB, Yalta K, Tandogan I, Yilmaz A. Prognostic relevance of coronary collateral circulation: Clinical and epidemiological implications. Int J Cardiol. 2009;137(3):300-1

A222. Yilmaz A, Yalta K, Turgut OO, Yilmaz MB, Erdem A, Karadas F, Ozyol A, Tandogan I.  The effect of smoking on cardiac diastolic parameters including Vp, a more reliable and newer parameter. Cardiol J. 2007;14(3):281-6.

A223.  Yalta K, Yontar C, Karadas F, Yilmaz MB, Turgut OO, Yilmaz A, Erdem A, Tandogan I.  Initial syncope associated with alternating attacks of supraventricular tachycardia and atrioventricular block long after surgical correction of tricuspid atresia. Cardiol J. 2008;15(2):186-8.

A224.  Turgut O, Yilmaz MB, Yalta K, Tandogan I.  Gamma-glutamyltransferase as a useful predictor for cardiovascular risk: Clinical and epidemiological perspectives. Atherosclerosis. 2009 ; 202(2): 348-9

A225.  Sasmaz H, Yilmaz MB.  Coronary Collaterals in Obese Patients: Impact of Metabolic Syndrome. Angiology. 2009;60(2):164-8

A226. Yilmaz MB, Guray Y, Altay H, Demirkan B, Caldir V, Guray U, Biyikoglu SF, Sasmaz H, Kisacik HL, Korkmaz S. Fate of Internal Mammary Artery Grafted to Left Anterior Descending Artery Is Influenced by Native Vessel Stenosis and Viable Myocardium. Angiology. 2009;60(2):201-6

A227. Aslan H, Turgut O, Yalta K, Yilmaz MB, Ozdemir R, Ermis N, Sezgin AT, Yetkin E, Tandogan I, Yilmaz A. Coronary collateral circulation: any effect on P-wave dispersion? Angiology. 2008 ;59(4):448-53.

A228. Yilmaz MB.  Levosimendan and ventriculo-arterial coupling. Acta Anaesthesiol Scand. 2008 Mar;52(3):449.

A229. Gulsun M, Yilmaz MB, Pinar M, Tonbul M, Celik C, Ozdemir B, Dumlu K, Erbas M.  Thorax deformity, joint hypermobility, and anxiety disorders. Saudi Med J. 2007 ;28(12):1840-4.

A230. Yilmaz A, Yalta K, Turgut OO, Yilmaz MB, Ozyol A, Erdem A, Tandogan I. Comparison of myocardial performance index versus ratio of isovolumic contraction time/ejection time in left ventricular systolic dysfunction. Adv Ther. 2007 ;24(5):1061-7.

A231. Yilmaz MB, Refiker M.  Beta blockers in systolic heart failure: do physicians need more courage? Am Heart J. 2007 ;154(5):e23

A232. Yilmaz MB, Yalta K, Yontar C, Karadas F, Erdem A, Turgut OO, Yilmaz A, Tandogan I.  Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine. Cardiovasc Drugs Ther. 2007 ;21(6):431-5. Epub 2007 Oct 20.

A233. Yilmaz MB, Cihan G, Guray Y, Guray U, Kisacik HL, Sasmaz H, Korkmaz S.  Role of mean platelet volume in triagging acute coronary syndromes. J Thromb Thrombolysis. 2008 ;26(1):49-54.

A234. Erdem A, Yilmaz MB, Yalta K, Turgut OO, Tandoğan I.  The severity of ST segment elevation in acute inferior myocardial infarction: does it predict the presence of a proximal culprit lesion along the right coronary artery course? Anadolu Kardiyol Derg. 2007 ;7 Suppl 1:189-90.

A235. Yilmaz MB.  Are there routes by which metabolic syndrome acts as an individual risk factor? Am J Cardiol. 2007 ;100(3):561-2.

A236. Yilmaz MB.  Statins and aortic stenosis in the context of ratio of low- to high-density lipoprotein cholesterol. J Am Coll Cardiol. 2007 ;50(3):289-90

A237. Yilmaz MB, Yalta K, Turgut OO, Yilmaz A, Yucel O, Bektasoglu G, Tandogan I.  Sleep quality among relatively younger patients with initial diagnosis of hypertension: dippers versus non-dippers. Blood Press. 2007;16(2):101-5.

A238. Yalta K, Turgut OO, Yilmaz A, Yilmaz MB, Manduz S, Karadas F, Dogan K, Tandogan I. Asymptomatic total anomalous pulmonary venous connection with double drainage in a young adult: a case report. Heart Surg Forum. 2007;10(3):E211-2.

A239. Yalta K, Erdem A, Yilmaz A, Turgut OO, Yilmaz MB, Yontar C, Tandogan I.  Heart rate turbulence: an additional parameter in determining the need for mechanical relief of mitral stenosis? J Heart Valve Dis. 2007 ;16(3):255-9.

A240. Yilmaz A, Yalta K, Turgut OO, Yilmaz MB, Karadas F, Erdem A, Ozyol A, Tandogan I.  The left anterior descending artery arising from the right sinus of Valsalva: a case report. Adv Ther. 2007 ;24(1):178-81.

A241. Turgut O, Yilmaz MB, Yilmaz A, Yalta K, Kendirlioglu O, Tandogan I.  Acute coronary syndrome: short-term effects of early intravenous metoprolol on maximum P wave duration and P wave dispersion. Adv Ther. 2007 ;24(1):14-22.

A242. Karadas F, Yalta K, Turgut OO, Yilmaz MB, Yilmaz A, Dogan K, Tandogan I. The effect of collateral circulation on left ventricular systolic function. Coron Artery Dis. 2007 ;18(3):169-73.

A243. Yilmaz MB, Karadas F, Erdem A, Tandogan I.  Improvement in Doppler alternans in patients with severe heart failure: Levosimendan versus dobutamin. Int J Cardiol. 2008 ;125(1):104-6.

A244. Yalta K, Yilmaz A, Turgut OO, Yilmaz MB, Karadas F, Bektasoglu G, Tandogan I.  Acute heart failure and near-syncope associated with giant left atrial ball thrombus occluding left ventricular inflow tract. Eur J Echocardiogr. 2008 ;9(1):86-7.

A245. Refiker M, Budak B, Demirkan B, Yilmaz MB.  Carney's syndrome: cardiac myxoma and Cushing's syndrome - a case report. Clin Res Cardiol. 2007 ;96(5):285-7.

A246. Yilmaz MB, Refiker M, Guray Y, Guray U, Altay H, Demirkan B, Caldir V, Korkmaz S.  Prescription patterns in patients with systolic heart failure at hospital discharge: why beta blockers are underprescribed or prescribed at low dose in real life? Int J Clin Pract. 2007 ;61(2):225-30.

A247. Yilmaz MB, Yontar OC, Turgut OO, Yilmaz A, Yalta K, Gul M, Tandogan I.  Herbals in cardiovascular practice: are physicians neglecting anything? Int J Cardiol. 2007 ;122(1):48-51.

A248. Yalta K, Turgut O, Yilmaz A, Yilmaz MB, Kendirlioglu O, Karadas F. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake. Int J Cardiol. 2007 ;116(3):e95-7.

A249. Yalta K, Turgut OO, Yilmaz A, Yilmaz MB, Ozyol A, Karadas F, Tandogan I. Left ventricular outflow tract myxoma accompanied by dextrocardia with situs inversus: a case report. Int J Cardiovasc Imaging. 2007 ;23(3):329-32.

A250. Yilmaz MB. Metabolic syndrome and extension of coronary atherosclerosis. Int J Cardiol. 2007 ;118(2):264; author reply 265-6.

A251. Guray U, Guray Y, Yilmaz MB, Caldir V, Cay S, Sasmaz H, Kormaz S.  Aortic pulse pressure and aortic pulsatility in patients with coronary slow flow. Cardiology. 2007;107(4):233-8.

A252. Yilmaz MB, Guray Y, Guray U, Cay S, Caldir V, Biyikoglu SF, Sasmaz H, Korkmaz S. Fine vs. coarse atrial fibrillation: which one is more risky? Cardiology. 2007;107(3):193-6.

A253. Yilmaz A, Yalta K, Turgut OO, Yilmaz MB, Ozyol A, Kendirlioglu O, Karadas F, Tandogan I. Clinical importance of elevated CK-MB and troponin I levels in congestive heart failure. Adv Ther. 2006 ;23(6):1060-7.

A254. Yalta K, Yilmaz A, Turgut OO, Erselcan T, Yilmaz MB, Karadas F, Yontar C, Tandogan I.  Evaluation of tumor markers CA-125 and CEA in acute myocardial infarction. Adv Ther. 2006 ;23(6):1052-9.

A255. Bitigen A, Tanalp AC, Kaynak E, Karavelioglu Y, Kirma C, Adas M, Yilmaz MB. Elastic properties of aorta in patients with primary hyperparathyroidism. Int J Clin Pract. 2006 ;60(12):1572-5.

A256. Yilmaz MB, Guray Y, Guray U, Biyikoglu SF, Tandogan I, Korkmaz S.  Metabolic syndrome increases the risk of significant coronary artery involvement in patients with peripheral artery disease. Coron Artery Dis. 2006 ;17(6):529-32.

A257. Yilmaz MB. Cytokines and coronary collaterals in patients with coronary artery disease. Am J Cardiol. 2006 ;98(3):423.

A258. Biyikoglu SF, Ege M, Yilmaz MB, Duru E, Sasmaz A. Acquired cardiac hypertrophy with outflow tract obstruction in a patient with severe Takayasu arteritis. Int J Cardiovasc Imaging. 2006 ;22(6):741-3.

A259. Bitigen A, Karavelioglu Y, Kaynak E, Yilmaz MB. A case of myocardial infarction due to acute left main coronary artery occlusion presenting with peculiar electrocardiographic changes. Int J Cardiovasc Imaging. 2006 ;22(3-4):343-7

A260. Yilmaz MB, Erbay AR, Balci M, Guray Y, Cihan G, Guray U, Kisacik HL, Korkmaz S.  Atrial natriuretic peptide predicts impaired atrial remodeling and occurrence of late postoperative atrial fibrillation after surgery for symptomatic aortic stenosis. Cardiology. 2006;105(4):207-12

A261. Yilmaz MB, Caldir V, Guray Y, Guray U, Altay H, Demirkan B, Cay S, Kisacik HL, Korkmaz S. Relation of coronary collateral vessel development in patients with a totally occluded right coronary artery to the metabolic syndrome. Am J Cardiol. 2006 ;97(5):636-9.

A262. Yilmaz MB, Pinar M, Naharci I, Demirkan B, Baysan O, Yokusoglu M, Erinc K, Tandogan I, Isik E. Being well-informed about statin is associated with continuous adherence and reaching targets. Cardiovasc Drugs Ther. 2005 ;19(6):437-40.

A263. Yilmaz MB, Guray U, Guray Y, Biyikoglu SF, Tandogan I, Sasmaz H, Korkmaz S.  Metabolic syndrome negatively impacts early patency of saphenous vein grafts. Coron Artery Dis. 2006 ;17(1):41-4.

A264. Yilmaz MB, Demirkan B, Caldir V, Guray Y, Guray U, Sasmaz H, Korkmaz S. Association of lipid profile with echocardiographic Wilkins score in patients with moderate to severe mitral stenosis: possible impact on prognosis. Int J Cardiol. 2006 ;112(3):329-33.

A265. Guray Y, Guray U, Altay H, Cay S, Yilmaz MB, Kisacik HL, Korkmaz S. Aortic pulse pressure and aortic pulsatility are associated with angiographic coronary artery disease in women. Blood Press. 2005;14(5):293-7.

A266. Cay S, Yilmaz MB, Korkmaz S. Intracranial bleeding associated with clopidogrel. Cardiovasc Drugs Ther. 2005 ;19(2):157-8.

A267. Yilmaz MB, Biyikoglu SF, Guray Y, Karabal O, Caldir V, Cay S, Sahin O, Sasmaz H, Korkmaz S. Level of awareness of on-treatment patients about prescribed statins. Cardiovasc Drugs Ther. 2004 ;18(5):399-404.

A268. Yilmaz MB, Balbay Y, Caldir V, Ayaz S, Guray Y, Guray U, Korkmaz S.  Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance. Thromb Res. 2005;115(1-2):25-9.

A269. Guray U, Erbay AR, Guray Y, Yilmaz MB, Boyaci AA, Sasmaz H, Korkmaz S, Kutuk E. Poor coronary collateral circulation is associated with higher concentrations of soluble adhesion molecules in patients with single-vessel disease. Coron Artery Dis. 2004 ;15(7):413-7.

A270. Yilmaz MB, Saricam E, Biyikoglu SF, Guray Y, Guray U, Sasmaz H, Korkmaz S. Mean platelet volume and exercise stress test. J Thromb Thrombolysis. 2004 ;17(2):115-20.

A271. Guray U, Guray Y, Ozbakir C, Yilmaz MB, Sasmaz H, Korkmaz S. Fistulous connection between internal mammary graft and pulmonary vasculature after coronary artery bypass grafting: a rare cause of continuous murmur. Int J Cardiol. 2004 ;96(3):489-92.

A272. Güray U, Erbay AR, Güray Y, Yilmaz MB, Boyaci AA, Sasmaz H, Korkmaz S, Kütük E. Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis. Int J Cardiol. 2004 ;96(2):235-40.

A273. Guray Y, Guray U, Yilmaz MB, Mecit B, Kisacik H, Korkmaz S.  Prevalence of angiographically significant coronary artery disease in patients with rheumatic mitral stenosis. Acta Cardiol. 2004 ;59(3):305-9.

A274. Erbay AR, Yilmaz MB, Balci M, Sabah I. Atrial natriuretic peptide levels in adult patients before and after surgery for correction of atrial septal defects: relationship with atrial arrhythmias. Clin Sci (Lond). 2004 ;107(3):297-302.

A275. Yilmaz MB, Guray U, Guray Y, Cihan G, Caldir V, Cay S, Kisacik HL, Korkmaz S. Lipid profile of patients with aortic stenosis might be predictive of rate of progression. Am Heart J. 2004 ;147(5):915-8.

A276. Guray U, Guray Y, Mecit B, Yilmaz MB, Sasmaz H, Korkmaz S. Maximum p wave duration and p wave dispersion in adult patients with secundum atrial septal defect: the impact of surgical repair. Ann Noninvasive Electrocardiol. 2004 ;9(2):136-41.

A277. Yilmaz MB, Akin Y, Biyikoglu SF, Guray U, Kisacik HL, Korkmaz S. Left ventricular thrombosis is associated with increased mean platelet volume in patients with dilated cardiomyopathy and sinus rhythm. Acta Cardiol. 2004 ;59(1):41-5.

A278. Yilmaz MB, Akin Y, Biyikoglu SF, Altay H, Guray U, Duru E, Korkmaz S. Fate of internal mammary artery grafted on to totally occluded coronary arteries. Int J Cardiol. 2004 ;93(2-3):305-6.

A279. Yilmaz MB, Akin Y, Biyikoglu SF, Guray U, Korkmaz S. Diffuse alveolar hemorrhage following administration of tirofiban in a patient with acute coronary syndrome: a fatal complication. Int J Cardiol. 2004 ;93(1):81-2.

A280. Yilmaz MB, Biyikoglu SF, Akin Y, Guray U, Kisacik HL, Korkmaz S. Obesity is associated with impaired coronary collateral vessel development. Int J Obes Relat Metab Disord. 2003 ;27(12):1541-5.

A281. Turhan H, Yilmaz MB, Yetkin E, Atak R, Biyikoglu SF, Senen K, Ileri M, Cehreli S, Korkmaz S, Kutuk E. Diagnostic value of aVL derivation for right ventricular involvement in patients with acute inferior myocardial infarction. Ann Noninvasive Electrocardiol. 2003 ;8(3):185-8.

A282. Yilmaz MB, Topologlu S, Akin Y, Guray U, Korkmaz S. Swyer-James syndrome with myocardial bridge: a case report. Int J Cardiol. 2003 ;91(1):103-5.

A283. Yilmaz MB, Tufekcioglu O, Korkmaz S, Sabah I. Dynamic cardiomyoplasty: impact of effective pacing. Int J Cardiol. 2003 ;91(1):101-2.

A284. Yilmaz MB, Ozeke O, Akin Y, Guray U, Biyikoglu SF, Kisacik HL, Korkmaz S. Platelet aggregation in left ventricular thrombus formation after acute anterior myocardial infarction: mean platelet volume. Int J Cardiol. 2003 ;90(1):123-5.

A285. Yilmaz MB, Kisacik HL, Korkmaz S. Persisting fever in a patient with brucella endocarditis: occult splenic abscess. Heart. 2003 ;89(7):e20.

A286. Yilmaz MB, Akin Y, Güray U, Kisacik HL, Korkmaz S. Late recurrence of left atrial myxoma with multiple intracranial aneurysms. Int J Cardiol. 2003 ;87(2-3):303-5.

A287. Yilmaz MB, Turhan H, Akin Y, Kisacik HL, Korkmaz S. Beta-blocker-induced psoriasis: a rare side effect--a case report. Angiology. 2002 ;53(6):737-9. Review.

A288. Yilmaz MB, Akarca E, Güray U. Subaortic stenosis caused by two discrete membranes. Heart. 2002 ;88(5):459.

A289. Yilmaz MB, Arat N, Biyikoglu SF, Korkmaz S, Sabah I. Extrinsic left atrial compression in a patient with achalasia. Int J Cardiol. 2002 ;85(2-3):301-3.

A290. Yilmaz MB, Akin Y, Güray U, Kisacik H, Korkmaz S. Spontaneous rectus muscle hematoma following streptokinase therapy for acute myocardial infarction: a case report. Int J Cardiol. 2002 ;84(1):101-3. Review.

A291. Turhan H, Yetkin E, Senen K, Yilmaz MB, Ileri M, Atak R, Cehreli S, Kutuk E. Effects of percutaneous mitral balloon valvuloplasty on P-wave dispersion in patients with mitral stenosis. Am J Cardiol. 2002 ;89(5):607-9.

A292.  Turgut O, Yilmaz A, Yalta K, Yilmaz BM, Ozyol A, Kendirlioglu O, Karadas F, Tandogan I. Tortuosity of coronary arteries: an indicator for impaired left ventricular relaxation? Int J Cardiovasc Imaging. 2007 ;23(6):671-7.

A293.  Turgut O, Yilmaz A, Yalta K, Karadas F, Birhan Yilmaz M. gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk. Med Hypotheses. 2006;67(5):1060-4.

A294.  Birhan Yilmaz M, Guray U, Guray Y, Altay H, Demirkan B, Caldir V, Cay S, Refiker ME, Sasmaz H, Korkmaz S. Metabolic syndrome is associated with extension of coronary artery disease in patients with non-ST segment elevation acute coronary syndromes. Coron Artery Dis. 2005 ;16(5):287-92.

A295.  Birhan Yilmaz M. Being obese with poor coronary collaterals in cardiogenic shock. Int J Cardiol. 2008 ;129(1):133

A296. Erdem A, Birhan Yilmaz M. Importance of levosimendan on right ventricular function in patients with biventricular heart failure. Crit Care Med. 2010 ;38(5):1389-90

A297. Refiker Ege M, Birhan Yilmaz M, Caldir V. Alveolar hemorrhage following tirofiban treatment. A misleading diagnosis. Rev Esp Cardiol. 2010 ;63(12):1511-2.